Connect public, paid and private patent data with Google Patents Public Datasets

Bone growth particles and osteoinductive composition thereof

Download PDF

Info

Publication number
US7718616B2
US7718616B2 US11614422 US61442206A US7718616B2 US 7718616 B2 US7718616 B2 US 7718616B2 US 11614422 US11614422 US 11614422 US 61442206 A US61442206 A US 61442206A US 7718616 B2 US7718616 B2 US 7718616B2
Authority
US
Grant status
Grant
Patent type
Prior art keywords
bone
collagen
composition
calcium
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US11614422
Other versions
US20080152687A1 (en )
Inventor
Kevin J. Thorne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zimmer Orthobiologics Inc
Original Assignee
Zimmer Orthobiologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers

Abstract

A biocompatible synthetic bone growth composition comprising a fibrillar collagen component and a calcium phosphate component. The composition is formed into particles, and then formed into a unitary article that may be provided at the site of a skeletal defect. An osteoinductive component may be further added, either before or after forming the unitary article. The composition may be formulated as a paste or putty and facilitates bone growth and/or repair.

Description

FIELD OF THE INVENTION

The invention relates generally to a composition comprising bone growth particles, a method of making the composition, and a use of the composition in promoting bone growth.

BACKGROUND

The use of osteoinductive proteins or growth factors, such as bone morphogenetic proteins (BMPs), mitogenic growth factors, etc., improves clinical outcomes after surgical reconstruction of skeletal defects (e.g., implants). Such osteoinductive factors induce bone formation by targeting and activating undifferentiated perivascular connective tissue cells. Mitogenic growth factors target and accelerate the osteogenic activity of previously differentiated cells. Although advances have improved the biological activity of osteoinductive factors, their clinical application has been limited by the requirement for a superior tissue scaffold/delivery vehicle.

Autologous bone grafts are the gold standard for restoring skeletal defects because they provide both a natural tissue scaffold and osteoinductive growth factors. Allogenic grafts may also be used, such as demineralized bone matrices. For example, demineralized bone material can be prepared by grinding a bone, demineralizing it with an acid solution, washing with a phosphate buffered solution, washing with ethanol and drying it. Demineralized bone material can also be obtained from a commercial bone or tissue bank (e.g., AlloSource, Denver Colo.). Because autogenic and allogenic sources of human bone are limited and may be expensive or painful to obtain, the use of substitute materials is preferred. Numerous synthetic or modified natural materials have been experimentally evaluated as alternative delivery vehicles, and include but are not limited to products containing hydroxyapatites, tricalcium phosphates, aliphatic polyesters (poly(lactic) acids (PLA), poly(glycolic)acids (PGA), polycaprolactone (PCL), cancellous bone allografts, human fibrin, plaster of Paris, apatite, wollastonite (calcium silicate), glass, ceramics, titanium, devitalized bone matrix, non-collagenous proteins, collagen and autolyzed antigen extracted allogenic bone. However, these synthetic or modified natural materials have yet to result in delivery vehicles having osteoinductivity comparable to autograft or allograft bone sources, or having the capability to enhance the osteoinductivity of these or other osteoinductive materials.

Alternate products are desirable.

SUMMARY OF THE INVENTION

Biocompatible compositions that comprise bone growth particles, a method of making the compositions, and uses of the compositions in promoting bone growth are disclosed. One embodiment is a bone growth-promoting composition comprising collagen and calcium phosphate that can be formulated as a paste or putty. The compositions and methods facilitate skeletal regeneration and provide a scaffold for new bone growth.

The compositions may be formulated as pastes or putties. This provides ease of use and economy of product manufacture. Pastes and putties are soft masses with physical consistencies between a liquid and a solid. Pastes and putties are desirable for surgical bone repair as they can be more easily delivered to difficult surgical sites and molded in site into desired shapes. These products are desirable for the reconstruction of skeletal defects, e.g., in spine, dental, and/or other orthopedic surgeries. They may be used as a substitute for autologous bone grafts or may be used in conjunction with autologous bone grafts.

In one embodiment, engineered (i.e., synthetic) composite products that enhance the in vivo formation of bone tissue and preserves the availability, and thus the functional activity of osteoinductive growth factors are disclosed. Local pH control enhances clinical efficacy of osteogenic proteins, and supplements local availability of essential bone components such as collagen, calcium, and phosphate. Moderately acidic microenvironments likely improve protein-stimulated osteoinduction by enhancing the rates of protein solubilization and protein release from collagen. Supplementing the local concentration of soluble [Ca2+] and [PO4 3−] ions enhances the quantity of bone produced, and increases rate of bone formation by reducing dependence on essential ion diffusion from serum and other body fluids. The resultant increase in local concentration and cellular availability of bone morphogenetic proteins result in improved acidic collagen delivery vehicles.

One embodiment is a biocompatible synthetic bone growth composition comprising a particulate composite of a fibrillar collagen component and a calcium phosphate component. The collagen component may be insoluble collagen (e.g., crosslinked collagen or porous particles). The calcium phosphate component may be acidic calcium phosphate, such as monocalcium phosphate [Ca(H2PO4)2], calcium hydrogen phosphate dihydrate [CaHPO4 2H2O], anhydrous calcium hydrogen phosphate [CaHPO4], partially dehydrated calcium hydrogen phosphate [CaHPO4xH2O, where x is between and includes 0 and 2] and/or calcium pyrophosphate [2CaO.P2O5]. In one embodiment, the composition contains an osteoinductive component, e.g., a purified bone growth factor, a recombinant bone growth factor, a bone marrow component, a blood component, demineralized bone, autologous bone, bone marrow aspirate, etc. In one embodiment, the composition pH ranges from about pH 5 to about pH 7.

Another embodiment is a process for producing a bone growth composition. A collagen component is combined with a calcium phosphate component to produce a mineralized collagen component. The mineralized collagen component may be prepared as a collagen gel, which may be frozen and lyophilized into a product referred to as a sponge. Particles of the mineralized collagen component (e.g. sponge) may be prepared by grinding, milling, chopping and/or molding the mineralized collagen component. The particulate composition may be packaged as a kit that may include a device (e.g., container) for mixing the particles with a fluid. An osteoinductive component may be added, either before or after forming the particles.

Another embodiment is a method of facilitating bone growth in a patient by adding an osteoinductive component to a particulate mineralized collagen component and implanting the composition in the patient. The composition may be injected into and/or molded to fit a surgical site.

These and other embodiments will be further appreciated with respect to the following drawings, description, and examples.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a schematic representation of a collagen scaffold.

FIG. 2 shows a flow chart representing a process for making a mineralized collagen component.

DETAILED DESCRIPTION

The basic elements required for bone formation include a three-dimensional, open-porosity tissue scaffold, cells, and osteoinductive signaling molecules to stimulate cell differentiation, proliferation and matrix formation. Successful bone formation requires that these elements be combined in a well-coordinated spatial and time dependent fashion. The relative contribution of each element may vary, e.g., according to differences in patient age, gender, health, systemic conditions, habits, anatomical location, etc.

Embodiments for improved bone formation and healing include the following: biocompatible, open-porous bone tissues scaffold, enhanced local concentration of soluble bone mineral elements such as calcium and phosphate, and preserved osteoinductive protein solubility. Each is subsequently analyzed.

A biocompatible, open-porous bone tissue scaffold restores function and/or regenerates bone by providing a temporary matrix for cell proliferation and extracellular matrix deposition with consequent bone in-growth until new bony tissue is restored and/or regenerated. The matrix may also provide a template for vascularization of this tissue. The scaffold may actively participate in the regenerative process through the release of growth differentiation factors.

The macro and micro-structural properties of the scaffold influence the survival, signaling, growth, propagation, and reorganization of cells. They may also influence cellular gene expression and phenotype preservation. The following properties contribute to scaffold characteristics for bone formation: cell biocompatiability, surface chemistry, biodegradability, porosity, and pore size.

In one embodiment, the composition comprises fibrillar collagen. Collagen is the main protein of connective tissue in animals and the most abundant protein in mammals. Bone is composed of strong, fibrillar bundles of collagen encased within a hard matrix of a calcium phosphate known as hydroxylapatite. Collagen is also a constituent in cartilage, tendon and other connective tissues.

The collagen protein possesses a distinctive triple-helix tertiary structure of three polypeptide chains supercoiled about a common axis and linked by hydrogen bonds. At least nineteen distinct molecules have been classified as collagens, and specific types are associated with particular tissues. Collagen can be converted into gelatin by boiling or treating with an acid. The solubility of collagen is affected by its conformation and extent of associations, whereby newly synthesized collagen chains are generally soluble but after formation of fibrils, they become essentially insoluble.

Collagen fibrils, referred to as fibrillar collagen, result from covalent cross-linking between the supercoiled chains by an enzymatic mechanism that strengthens and stabilizes the chains. Fibrillar collagen may be obtained from native sources such as human or animal dermis, tendon, cartilage or bone. It is generally recovered by proteolytically degrading natural collagen crosslinks to produce tropocollagen. Tropocollagen, the basic amino acid component, is soluble with acidic solutions (in one embodiment, between pH 3 to pH 4). These solutions can be cleaned and purified prior to collagen fiber reassembly by pH neutralization. Fibrillar collagen is generally less dense, less soluble, and swells more in solution than non-fibrillar collagen.

Due to its high degree of biocompatibility with the human body, collagen has been successfully used in a variety of medical and dental applications for many years with minimal adverse responses. During its manufacture, potentially antigenic portions of the collagen molecule are removed, resulting in a product that is highly biocompatible and well-tolerated by the tissue. Collagen is also chemotactic for fibroblasts and other cells involved in bone tissue repair. Collagen biocompatibility ensures that the products are well integrated in the host tissue without eliciting an immune response.

Collagen used in the particulate composition may be from any source. These include natural sources such as human and mammalian tissues, and synthetic sources manufactured using recombinant technologies. It may be of any type (e.g., collagen Types I, II, III, X and/or gelatin). In one embodiment, collagen used is Type I collagen. In one embodiment, collagen is derived from bovine dermis. In one embodiment, fibrillar collagen is derived from bovine dermis manufactured by Kensey Nash Corporation (Exton Pa.) under the name Semed F. In one embodiment, fibrillar collagen may be obtained from Kensey Nash Corporation under the name P1000. In one embodiment, the particles comprise at least about 33 percent by dry weight collagen. In another embodiment, the particles comprise from about 25 percent to about 75 percent dry weight collagen.

The surface chemistry of the scaffold can control and affect cellular adhesion. It can also influence the solubility and availability of proteins essential for intracellular signaling. Intracellular signaling maximizes osteoinductivity through controlled cellular differentiation, proliferation, and stimulation.

Collagen fabricates the disclosed structural scaffold and provides a physical and chemical milieu favorable to bone regeneration. Collagen also provides a favorable extracellular matrix for bone forming cells, e.g., osteoblasts, osteoclasts, osteocytes, etc. The bone forming cells' natural affinity for the collagen matrix has been demonstrated to favorably influence the function and signaling required for normal cellular activity.

The degradation rate of the scaffold should ideally match the bone-healing rate. Slower degradation rates can hinder the rate of remodeled, load-bearing bone formation. Faster degradation can result in unhealed defects.

The solubility and resorption of collagen is affected by its conformation and the degree of collagen cross-linking. The in vivo solubility and resorption of collagen is also influenced by the local concentration of proteolytic agents and vascularity at the site.

In one embodiment, the composition is crosslinked to control the solubility and the extent and rate of collagen resorption. Collagen crosslinking may occur by various methods such as dehydrothermal (DHT), UV light exposure, chemical crosslinking with aldehydes (i.e. glyceraldehyde, formaldehyde, glutaraldehyde), carbodiimides and various amino acids. The crosslinking conditions will preserve the in vivo lifetime of the composition for up to about twelve weeks, allowing it to function as a scaffold for bone healing. Collagen is eventually absorbed into the surrounding tissue by host enzymes. In one embodiment, uncrosslinked collagen may be a component of the composition.

Scaffolds desirably posses an open pore, fully interconnected geometry to allow homogeneous and rapid cell in-growth, and facilitate vascularization of the construct from the surrounding tissue.

To this end, the total pore volume porosity of the scaffold simulates that of cancellous bone. Cancellous bone is a highly porous structure (about 50 vol. % to about 90 vol. %) arranged in a sponge-like form, with a honeycomb of branching bars, plates, and rods of various sizes called trabeculae. The synthetic scaffold must ensure pore interconnectivity to allow for the diffusion of nutrients and gases and for the removal of metabolic waste resulting from the activity of the cells within the scaffold. It is generally accepted by one skilled in the art that the pore diameters should be within the range of about 200 μm to about 900 μm range for ideal bone formation. Smaller pores can occlude and restrict cellular penetration, matrix production, and tissue vascularization. Larger pores can detrimentally influence the mechanical properties of the structural scaffold.

The disclosed method produces a synthetic scaffold that mimics the natural structural design of bone for bone formation. In one embodiment, the scaffold is fabricated using fibrillar collagen. Fibrillar collagen is the cytoskeletal filament within the matrix of all tissues and organs. In addition to being a fundamental element of natural bone, fibrillar collagen allows the formation of a scaffold with high surface area and an interconnected network of high porosity, as shown in FIG. 1. The total pore volume is made up of both micropores 10, which is the space between collagen strands within the fibril and macropores 12, which is the space between collagen fibrils. In one embodiment, the composition matches the porosity of cancellous bone, with total pore volumes ranging between about 50 vol. % to about 97 vol. % and pore diameters ranging between 1 μm and 1000 μm.

Enhancing local concentration of soluble bone mineral elements, such as [Ca2+] and/or [PO4 3−], contributes to improved bone formation and healing.

Calcium phosphate based products have been used for bone repair for over 80 years. Their many desirable properties include similarity in composition to bone mineral, bioactivity (ability to form apatitic or carbonated hydroxylapatite on their surfaces), ability to promote cellular function and expression, ability to form a direct strong interface with bone, and osteoconductivity (ability to provide a scaffold or template for the formation of new bone). Commercially available calcium phosphate biomaterials differ in origin (e.g., natural or synthetic), composition (e.g., hydroxylapatite, beta-tricalcium phosphate, and biphasic calcium phosphate), physical forms (e.g., particulates, blocks, cements, coatings on metal implants, composites with polymers), and physicochemical properties. Subtle differences in chemical composition and crystalline structure may significantly impact their in vivo physical and biological performance.

The disclosed composition and method supplements the local availability of essential soluble bone components, e.g., calcium and phosphate. Biologically compatible, sparingly soluble calcium phosphates are suitable supplements to locally increase the supply of soluble calcium [Ca2+] and phosphate [PO4 3−] ions. As shown in Table 1, calcium phosphate salts solubilize at different equilibrium ionic concentrations, where the local supplemented concentrations of calcium [Ca2+] and phosphate [PO4 3−] ions can vary by more than four orders of magnitude. Calcium hydrogen phosphate (dical), an example of a calcium phosphate additive used in the disclosed composition, provides about 200 to about 300 times the concentration of soluble mineral elements in comparison to conventional calcium phosphates, such as tricalcium phosphate (TCP) (Ca3(PO4)2) or tetracalcium phosphate (TTCP) (Ca4(PO4)2(OH)2) or calcium hydroxyapatite (HA) (Ca5(PO4)3(OH)).

TABLE 1
Equilibrium solubility of calcium and phosphate ions from several
different biologically compatible calcium phosphate salts.
Equilibrium Equilibrium Insoluble fraction
[Ca2+] [PO4 3−] [200 mg/cc]
Plasma 2,200.0 μM   1,100.0 μM  
Ca(H2PO4)2 (Monocal) 14,300.0 μM    28,600.0 μM    97.0000 wt. %
CaHPO4 (Dical) 480.0 μM  480.0 μM  99.9700 wt. %
Ca3(PO4)2 (TCP) 1.4 μM 0.9 μM 99.9999 wt. %
Ca5(PO4)3(OH) (HA) 2.2 μM 1.3 μM 99.9999 wt. %
Ca4(PO4)2(OH)2 (TTCP) 28.2 μM  14.1 μM  99.9994 wt. %

Dical is soluble and does not require osteoclastic resorption for biodegradation. It resorbs slowly enough that products can be designed to supplement the soluble mineral ion concentration for several weeks.

Local supplementation of soluble [Ca2+] and [PO4 3−] ions enhanced the quantity of bone produced and increased its rate of formation in animals. Without being bound by a specific theory, it is believed that the use of a soluble form a calcium phosphate reduces the healing rate dependence on local osteoclastic resorption and essential ion diffusion from plasma fluids.

The method and composition preserved osteoinductive protein solubility. Osteoinduction is the process by which stem cells and osteoprogenitor cells are recruited to a bone-healing site and are stimulated to undergo the osteogenic differentiation pathway. Classic synthetic, biodegradable scaffolds are only osteoconductive and require combination with an inductive bone-forming agent to stimulate and accelerate bone healing.

Bone growth factor cytokines, also known as bone morphogenetic proteins (BMPs), are entrapped at high concentration within bone and are secreted by many bone-forming cell types. The primary function of BMPs is cellular signaling. Intracellular signaling occurs through the binding of a soluble growth factor to a specific cell receptor site. This signal pathway stimulates several different and important bone healing events, including the proliferation, migration, and differentiation of bone forming cells. The cells are, in turn, responsible for the synthesis of other proteins and growth factors that are important for regulating and controlling bone tissue formation. Although there is a vast array of BMPs described and known to one skilled in the art, BMPs 2, 4, 6 and 7 are generally considered to be the most osteoinductive.

The disclosed composition provides biodegradable synthetic bone graft materials to specifically preserve the solubility of osteoinductive proteins. Various forms of calcium phosphates are known to have different chemical affinities for endogenous osteoinductive proteins (e.g., BMPs). Calcium phosphates such as TCP and HA are known to strongly bind acid-soluble BMPs because of their alkaline surface chemistry. In contrast, dical presents a moderately acidic surface chemistry that will not bind acidic proteins. Because of its enhanced solubility, it can also moderately buffer the local environment to an acidic range that further preserves osteoinductive BMP solubility.

An in vitro study assessed the influence of variable composition calcium phosphate salts on the soluble concentration of osteoinductive proteins. The residual concentration of soluble recombinant BMP-2 was measured after exposing a controlled concentration aliquot to an equi-molar quantity of calcium phosphate salt. As shown in Table 2, moderately acidic calcium phosphates salts, such as dical, preserved the highest soluble concentration of osteoinductive proteins. The enhanced local concentration and cellular availability of bone morphogenetic proteins (BMPs) better stimulate bone formation.

TABLE 2
Equilibrium solubility of osteoinductive recombinant human BMP-2
protein in the presence of equimolar concentrations of various
calcium phosphates.
[rhBMP-2]
mg/ml [rhBMP-2] %
Control 15.0 100%
Ca(H2PO4)2 (monocal) 15.0 100%
CaHPO4 (dical) 11.4 76%
Ca3(PO4)2 (TCP) 3.5 23%
Ca5(PO4)3(OH) (HA) 2.3 15%

In one embodiment, an additive (e.g., an osteoinductive component) formulated as a putty or paste is included in the biocompatible composition that facilitates skeletal regeneration and provides a scaffold for new bone growth. Use of synthetic components reduces the potential of disease transfer and immune system incompatibilities. The terms putty and paste are qualitative and generally describe a composition that is moldable/formable and flowable, respectively. When the term paste is used to describe the composition including a liquid, it is to be understood that a putty may also be formed, generally by decreasing the volume of liquid mixed with the composition.

In one embodiment, the composition forms a paste that enhances the formation of bone tissue and increases the availability, and thus the functional activity of osteoinductive growth factors. It is provided at a surgical site during reconstruction of a skeletal defect. For example, the paste may be used in spine, dental, reconstructive, trauma, and other orthopedic surgeries. The paste may be used as a substitute for or additive to autologous bone grafts. Although the composition is synthetic, it may include natural components, e.g., bovine collagen, and/or be combined with natural components, e.g., bone marrow aspirate.

The paste controls pH to enhance clinical efficacy of osteoinductive proteins, and supplements local availability of bone components such as collagen, calcium, and phosphate. Without being bound by a specific theory and as analyzed above, moderately acidic microenvironments likely improve protein-stimulated osteoinduction by enhancing the degree of protein solubilization and protein release from collagen. Supplementing the local concentration of soluble [Ca2+] and [PO4 3−] ions increases the rate of bone formation by reducing dependence on ion diffusion from serum and other body fluids. The resultant increase in local concentration of collagen and mineral building blocks, coupled with the enhanced cellular availability of bone morphogenetic proteins, improves acidic collagen delivery vehicles.

In one embodiment, the composition formulated as a paste is both osteoinductive, i.e., it initiates or induces bone growth, and osteoconductive, i.e., it facilitates already initiated bone growth but does not itself initiate bone growth. Its osteoinductive effect arises, for example, from osteoinductive factors present in the liquid, e.g., bone marrow aspirate, used to make the paste. The composition is also osteoinductive in that it does not inhibit or diminish the solubility of osteoinductive factors, such as BMPs, due to the ability of the composition to induce a local pH decrease, as analyzed above. Its osteoconductive effect arises from provision of a collagen scaffold and source of bone growth materials. In one embodiment, exogenous osteoinductive factors are included as additives in the composition.

A variety of calcium phosphate salts, represented by the general chemical formula xCaO,P2O5, may be used to simultaneously supplement the local [Ca2+] and [PO4 3−] ion concentrations and to act as short-term biologic buffers. In one embodiment, the composition includes a particulate formed from crosslinked collagen and calcium phosphate.

In another embodiment, a method of making the particulate composition is provided. Collagen and calcium phosphate are combined, dried, crosslinked, and particulated as subsequently described.

In another embodiment, a method of using the collagen and calcium phosphate particles is disclosed. The particulate composition can be combined with a fluid, for example bone marrow aspirate, to create a paste. The paste is then injected, manually applied, or otherwise delivered to a site of a bone. In one embodiment, the paste is an injectible bone void filler. The paste provides improved handling and delivery capabilities, allowing a surgeon to introduce the composition into complex geometry bone defects. The paste components are fully resorbable and stimulate bone regeneration in a manner similar to that achieved with natural bone.

In one embodiment, the composition contains particulate, fibrillar collagen and calcium phosphate. The composition can be combined with a liquid such as biological fluids (e.g., bone marrow aspirate, whole blood, serum, plasma, etc.) to form a paste. The paste is then used as an injectible and/or conformable (i.e., moldable) bone-grafting material for primary applications in, e.g., spine fusion, dental furcation augmentation, fracture repair, etc.

In one embodiment, where a fibrillar collagen component is combined with a calcium phosphate component to produce a mineralized collagen component, porous particles of the mineralized collagen component may be prepared. In one embodiment, particle porosity measured as the total open pore volume is greater than about 90 percent by volume. In another embodiment, the total open pore volume within the particle ranges from about 50 percent to about 97 percent. In one embodiment, particle pore size ranges from about 1 μm to about 1000 μm. In another embodiment, particle pore sizes range from about 125 μm to about 300 μm. In one embodiment, the particle size ranges from about 100 μm to about 840 μm.

A variety of calcium phosphate salts, represented by the general chemical formula Cax(PO4)y(O,OH,H2O) may be used in the product composition to simultaneously supplement the local concentration of [Ca2+] and [PO4 3−] ion concentrations and to act as short-term biologic buffers. Calcium phosphates that may be used in the composition include monocalcium phosphate (monocal) [Ca(H2PO4)2], calcium hydrogen phosphate (dical) [CaHPO4], calcium pyrophosphate [2CaO.P2O5], tricalcium phosphate [3CaO.P2O5], hydroxyapatite [3.33CaO.P2O5(OH)2 (polycrystalline and amorphous compositions)], tetracalcium phosphate [4CaO.P2O5] and calcium carbonate [CaCO3 (aragonite), CaCO3 (calcite)]. In one embodiment, the composition comprises an acidic mixture of calcium phosphates. Acidic calcium phosphate refers to those compositions, with composite calcium (x)/phosphate (y) below 1.5, that either present acidic surface chemistries or solubilize in aqueous solution to a sufficient extent to cause solution buffering to an acidic value (pH<7.0). In one embodiment, the acidic calcium phosphate is calcium hydrogen phosphate dihydrate [CaHPO4.2H2O]. In one embodiment, the acidic calcium phosphate is anhydrous calcium hydrogen phosphate [CaHPO4]. In one embodiment, the calcium phosphate of the composition is greater than about 25 percent by dry weight. In another embodiment, the calcium phosphate of the particulate composition is about 67 percent by dry weight.

The composition may further comprise additives such as bioactive agents, e.g., agents that exhibit biologic activity, and liquids. For example, agents that are osteoinductive and/or osteogenic may be included. As previously stated, osteoinductive agents stimulate bone growth. Examples of osteoinductive agents include bone growth factors, bone marrow components, blood components, and bone components. Bone growth factors may be purified or recombinant and include bone morphogenetic protein (BMP). Bone marrow aspirates (BMA) may be used in the composition because they contain osteoinductive agents such as bone growth factors and mesenchymal stem cells. Mesenchymal stem cells (MSCs) are multi-potent cells capable of differentiating along several lineage pathways to aid in the production of bone. MSCs are considered as a readily available source of cells for many tissue engineering and regenerative medicine applications. For these reasons, osteoinductive proteins and MSCs have been used to supplement the performance of osteoconductive bone formation scaffolds as replacements for autologous and allogeneic bone grafts.

In one embodiment, bone marrow aspirate is included in the composition. Blood components such as whole blood and platelet-rich plasma, may be included in the composition. Osteoinductive bone components that may be included in the composition include demineralized bone and autologous bone. Demineralized bone refers to bone that has been treated to remove all or a majority of the calcium phosphate mineral components. Demineralization is usually performed by exposing powdered bone, from any human or mammalian source, to acidic solutions (i.e., HCl, acetic acid, ethylene diamine tetracetic acid) with a pH less than about 4. Bone that has not been demineralized may be included in the composition and also includes bone derived from an autologous or mammalian source.

Adding liquid to the composition results in a paste or putty, defined as soft masses with physical consistencies between a liquid and a solid. The liquid may be a biological fluid such as blood, plasma, serum, bone marrow, etc., or may be a buffer or may be capable of buffering to the physiological pH values of human serum (pH 7.1 to pH 7.4). Examples of buffers are known to one skilled in the art and include Tris and phosphate-buffered saline. In one embodiment, the composition has a pH in the range of about pH 5 to about pH 7.4. In another embodiment, the composition has a pH in the range of about pH 5.5 to about pH 6.9. More than one liquid may be included in the composition. For example, the composition may include bone marrow aspirate and a buffering salt solution. The liquid may also include biocompatible liquids such as water, saline, glycerin, surfactants, carboxylic acids, dimethylsulfoxide, and/or tetrahydrofuran. In one embodiment, the liquid is greater than about 25 percent by volume of the composition. In another embodiment, the liquid comprises from about 75 percent to about 90 percent by volume of the composition. Additionally, natural and synthetic polymers such aliphatic polyesters, polyethylene glycols, polyanhydrides, dextran polymers, and/or polymeric orthophosphates may be included in the composition.

In one embodiment, a process for producing a particulate mineralized collagen composition comprising collagen and calcium phosphate is provided. In one embodiment, a crosslinked collagen and calcium phosphate composition is prepared and is then formed into particles, as shown in FIG. 2. Initially, collagen and calcium phosphate are combined with an acid, e.g. HCl, to create a slurry. The slurry may also be a gel due to the presence of collagen in an acidic environment. The types of collagen that may be used are described above and include bovine dermal fibrillar collagen. Suitable calcium phosphate includes acidic calcium phosphate such as monocalcium phosphate [Ca(H2PO4)2], calcium hydrogen phosphate [CaHPO4], and/or calcium pyrophosphate [2CaO.P2O5]. In one embodiment, about 33 percent by weight of collagen is combined with about 67 percent by weight calcium phosphate.

The combination is then subjected to freezing, lyophilization, and crosslinking. In one embodiment, the composition is frozen at about −80° C. for about two hours. In one embodiment, the composition is lyophilized for at least about sixteen hours. In another embodiment, the composition is lyophilized for at least about 48 hours.

The composition may be crosslinked. Crosslinking may be effected by a variety of methods known to one skilled in the art, including but not limited to dehydrothermal (DHT) crosslinking. In DHT crosslinking, the composition is placed in a vacuum oven chamber, the chamber is evacuated to create a vacuum, and the composition is heated for a period of time. In one embodiment, the composition is heated to about 110° C. In one embodiment, the composition is heated in a vacuum oven for about 48 hours.

Following freezing, lyophilization, and crosslinking, the solid composition is formed into particles. Methods of forming particles are known to one skilled in the art and include, but are not limited to, grinding, milling, chopping, and/or molding. In one embodiment, particles are formed by milling the solid composition. Milling may occur using a Wiley mill (Thomas Scientific, Swedesboro N.J.). The mesh size on the mill directs the size of the resultant particles. In one embodiment, a −20 mesh is used that creates particles in the range of about 100 μm to about 840 μm. The particles may be sized by, for example, sieving. At any point in the process, additional components may be added to the composition, as described above. For example, an osteoinductive component can be added prior to forming the articles.

The composition may be provided as a kit. In one embodiment, the kit includes the composition described above, and may further include other components. These include a receptacle such as a plastic container in which to place the composition and in which to add liquid to form the composition into a paste or putty, a mixing implement such as a spatula, stir rod, etc., a disposable syringe barrel without a needle in which to place and deliver the mixed paste, instructions for formulating and/or using the composition, etc.

In another embodiment, a method of facilitating bone growth is provided. In one embodiment, the method includes adding at least one osteoinductive component such as a purified bone growth factor, a recombinant bone growth factor, a bone marrow component, a blood component, demineralized bone, autologous bone, etc., to the particulate composition previously described. In embodiments where the osteoinductive component is bone marrow aspirate, blood, or a blood component, it may be acutely obtained and added to the composition (e.g., blood and/or bone marrow may be obtained from the same surgical site for repairing the defect). Adding the osteoinductive component(s) and/or another liquid to the composition, with stirring, results in a paste or putty, which is provided to the desired anatomical site of the patient. In one embodiment, the paste is loaded into the barrel of a disposable 5 cc syringe, without a needle attached, and is extruded through the barrel aperture to the desired anatomical site. In another embodiment, the putty is manipulated or formed into a configuration of desired size, shape, length, etc., either manually or by instrumentation, and gently pressed on and/or in the desired anatomical site. The site is desirably prepared to expose healthy bleeding bone, facilitating subsequent bone growth. The method may be performed using minimally invasive procedures known to one skilled in the art. The method may be used in at least partially filling bone voids and/or gaps of the skeletal system (i.e., extremities, pelvis, spine, oral cavity) that are not intrinsic to the stability of the bone structure. These voids and/or gaps may be a result of trauma, either natural or by surgical creation. The paste is gently provided on and/or in the void and/or gap. The paste is resorbed by the body during the healing process (over days, weeks, and months). The paste may be molded into the bone void or defect by manipulating either manually or using an instrument (e.g., spatula, syringe, probe, cannula, etc.).

The following examples further illustrate embodiments of the invention.

EXAMPLE 1

A composite collagen and calcium phosphate gel dispersion was prepared (5 vol. % collagen gel) by weighing 6 g collagen. A 10 mM HCl solution was volumetrically measured (246 ml) to prepare a 5 vol. % gel. Twelve g sterilized dicalcium phosphate [CaHPO4] powder (66.7 wt. % calcium phosphate) was added and stirred to a uniform consistency. The combination was mixed, for example, by repeated shear material transport, until a uniform collagen gel dispersion of moderate viscosity (about 1,000 P to about 1,500 P) was obtained.

About 16.5 ml of the collagen and calcium phosphate gel dispersion was then cast into an autoclaved TEFLON® mold of 4.5 cm (L)×1.7 cm (W)×2.1 cm (H), with removable upper and lower autoclaved glass plates. The collagen gel dispersion was injected into the mold with the lower glass plate attached and the composition was evenly spread using a spatula. The upper autoclaved glass plate was then fixed in contact with the dispersion and the plates were secured using countersunk flat head screws. The mold was then maintained at −80° C. for at least one hour.

After freezing, the glass plates were removed from both sides of the mold backing and the mold containing the frozen product was placed in a sterile paper autoclave pouch and frozen within a glass lyophilization vessel for two hours.

The frozen composition was then lyophilized (i.e. freeze-dried) at room temperature in a Laboratory Freeze Dryer (Freezemobile 25EL, VirTis Inc., Gardiner N.Y.) for at least 24 hours. The lyophilization vessel containing the product was attached to the vacuum port of the Freezemobile in operation with a condenser temperature of −50° C. or below, and a manifold pressure of 10−3 mm Hg or less. The vacuum port to the vessel was opened exposing the frozen product to pressure sufficient to freeze dry the product within 24 hours at room temperature.

The composition was then crosslinked via a dehydrothermal (DHT) process. The composition was removed from the mold and placed onto an autoclaved aluminum pan. The samples were then placed into a vacuum oven. The gas vents were closed and the chamber was evacuated to 10−3 mm Hg. The vacuum chamber was heated to 110° C. After 48 hours of constant temperature heating, the samples were cooled to room temperature (about 20° C. to about 22° C.) under vacuum. After the composition bar cooled, the chamber was repressurized with 0.2 micron filtered air. The composition bar was removed using sterile forceps and stored in a sterile paper autoclave pouch.

The samples were then processed into particles. Samples were placed into the hopper of a clean Wiley Mini-Mill (Thomas Scientific, Swedesboro N.J.), and milled at about 1,700 rpm. The samples were swept around by rotor until cut to sufficient fineness to pass through the sieve top of a delivery tube that formed the bottom of the chamber. The final product was collected using a 20 mesh delivery unit located under the mill blades.

In one embodiment, the particles were also subjected to compression molding to form storage disks. The particles were weighed and introduced into a cylindrical mold to produce solid disks through uni-axial compression. The compression pressure was optimized to simultaneously produce a solid product. This product resisted breakage during normal shipping and facilitated rapid product mixing (less than two min).

EXAMPLE 2

Prior to opening a container containing particles of the above composition, the volume of a bone void to be repaired was determined. Based on the bone void, an appropriate volume of non-human animal blood was obtained, using a ratio of 0.75:1 blood or bone marrow aspirate:bone void volume. Appropriate volumes of liquid were added, as subsequently described, to obtain products of desired cohesive consistency (e.g. paste). As one example, per 1 cc dry particle volume, 0.75 ml whole blood was added to obtain a cohesive putty, or 0.85 ml whole blood was added to obtain a paste. As another example, per 1 cc dry particle volume, 0.75 ml bone marrow aspirate was added to obtain a cohesive putty, or 0.85 ml bone marrow aspirate was added to obtain a paste.

Immediately prior to implantation on an isolated bone, the liquid was mixed with the composition to obtain a paste of desired consistency. The bone void site was irrigated as needed and the paste was packed into the bone void. The site was sealed with surrounding soft tissue as needed, e.g., to close the wound and restore soft tissue configuration. Rigid fixation of the defect site stabilized the bone void.

It should be understood that the embodiments and examples described are only illustrative and are not limiting in any way. Therefore, various changes, modifications or alterations to these embodiments may be made or resorted to without departing from the spirit of the invention and the scope of the following claims.

Claims (14)

1. A process for producing a bone growth composition comprising combining a fibrillar collagen component with an acidic calcium phosphate component to produce a mineralized collagen component, and creating particles of the mineralized collagen component, wherein the mineralized collagen component comprises the form of a crosslinked sponge prior to creating the particles, wherein creation of the particles includes milling.
2. The process of claim 1 wherein the mineralized collagen component comprises the form of a gel prior to creating the particles.
3. The process of claim 1 comprising adding an osteoinductive component to the composition.
4. The process of claim 3 wherein the osteoinductive component is added after the particles are formed.
5. The process of claim 1 wherein combining a fibrillar collagen component with an acidic calcium phosphate component to produce a mineralized collagen component further comprises preparing a collagen gel.
6. The composition of claim 5 further comprising lyophilizing the mineralized collagen compomnent.
7. The process of claim 1 wherein the acidic calcium phosphate is selected from the group consisting of monocalcium phosphate [Ca(H2PO4)2], calcium phosphate dibasic [CaHPO4], calcium pyrophosphate [2CaO.P2O5], and combinations thereof.
8. The process of claim 7 wherein the acidic calcium phosphate comprises calcium phosphate dibasic [CaHPO4].
9. The process of claim 1 wherein collagen is dehydrothermally crosslinked.
10. A process for producing a bone growth composition comprising combining a fibrillar collagen component with an acidic calcium phosphate component to produce a mineralized collagen component, and creating particles of the mineralized collagen component, wherein the mineralized collagen component comprises the form of a crosslinked sponge prior to creating the particles, further comprising including the particles in a kit.
11. The process of claim 10 wherein the kit includes a device for mixing the particles with a fluid.
12. The process of claim 10 wherein the kit includes a receptacle for mixing the particles with a fluid.
13. A process for producing a bone growth composition comprising combining a fibrillar collagen component with an acidic calcium phosphate component to produce a mineralized collagen component, and creating particles of the mineralized collagen component, wherein the mineralized collagen component comprises the form of a crosslinked sponge prior to creating the particles, further comprising sizing the particles.
14. The process of claim 13 wherein the size of the particles is selected by sieving.
US11614422 2006-12-21 2006-12-21 Bone growth particles and osteoinductive composition thereof Active US7718616B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11614422 US7718616B2 (en) 2006-12-21 2006-12-21 Bone growth particles and osteoinductive composition thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11614422 US7718616B2 (en) 2006-12-21 2006-12-21 Bone growth particles and osteoinductive composition thereof
CA 2673337 CA2673337C (en) 2006-12-21 2007-11-29 Bone growth particles and osteoinductive composition thereof
PCT/US2007/085853 WO2008076604A1 (en) 2006-12-21 2007-11-29 Bone growth particles and osteoinductive composition thereof
EP20070864863 EP2109444B1 (en) 2006-12-21 2007-11-29 Bone growth particles and osteoinductive composition thereof
JP2009543018A JP5399264B2 (en) 2006-12-21 2007-11-29 Bone growth particles and their osteoinductive composition
US12748999 US8742072B2 (en) 2006-12-21 2010-03-29 Bone growth particles and osteoinductive composition thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12748999 Continuation US8742072B2 (en) 2006-12-21 2010-03-29 Bone growth particles and osteoinductive composition thereof

Publications (2)

Publication Number Publication Date
US20080152687A1 true US20080152687A1 (en) 2008-06-26
US7718616B2 true US7718616B2 (en) 2010-05-18

Family

ID=39099623

Family Applications (2)

Application Number Title Priority Date Filing Date
US11614422 Active US7718616B2 (en) 2006-12-21 2006-12-21 Bone growth particles and osteoinductive composition thereof
US12748999 Active US8742072B2 (en) 2006-12-21 2010-03-29 Bone growth particles and osteoinductive composition thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12748999 Active US8742072B2 (en) 2006-12-21 2010-03-29 Bone growth particles and osteoinductive composition thereof

Country Status (5)

Country Link
US (2) US7718616B2 (en)
JP (1) JP5399264B2 (en)
CA (1) CA2673337C (en)
EP (1) EP2109444B1 (en)
WO (1) WO2008076604A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090110710A1 (en) * 2002-06-13 2009-04-30 Evans Douglas G Devices and methods for treating defects in the tissue of a living being
US20110157056A1 (en) * 2009-12-23 2011-06-30 Colin Karpfinger Tactile touch-sensing interface system
WO2013106318A1 (en) 2012-01-09 2013-07-18 Zimmer, Inc. Composite device that combines porous metal and bone stimuli
US8546456B2 (en) 2008-07-25 2013-10-01 Smith & Nephew, Inc. Fracture fixation systems
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
WO2013169475A1 (en) 2012-05-08 2013-11-14 Neal David J Porous spacers, instruments, and methods for foot and ankle fusion
DE102012209909A1 (en) * 2012-06-13 2013-12-19 Technische Universität Dresden Homogenized Kompaktkomposit, process for its preparation and composite powder and its use
US8613938B2 (en) 2010-11-15 2013-12-24 Zimmer Orthobiologics, Inc. Bone void fillers
US8690874B2 (en) 2000-12-22 2014-04-08 Zimmer Orthobiologics, Inc. Composition and process for bone growth and repair
US8742072B2 (en) * 2006-12-21 2014-06-03 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
WO2015147795A1 (en) * 2014-03-24 2015-10-01 Cormatrix Cardiovascular, Inc Sternal closure apparatus, system and method
WO2015147794A1 (en) * 2014-03-24 2015-10-01 Cormatrix Cardiovascular, Inc. Artificial skeletal material and constructs formed therefrom

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
JP5605618B2 (en) * 2009-06-09 2014-10-15 学校法人大阪医科大学 Bone regeneration material kits, pasty bone regeneration material, bone regeneration materials and osteosynthesis material
US20110206828A1 (en) * 2009-07-10 2011-08-25 Bio2 Technologies, Inc. Devices and Methods for Tissue Engineering
US8337876B2 (en) 2009-07-10 2012-12-25 Bio2 Technologies, Inc. Devices and methods for tissue engineering
US9775721B2 (en) 2009-07-10 2017-10-03 Bio2 Technologies, Inc. Resorbable interbody device
US8758791B2 (en) 2010-01-26 2014-06-24 Warsaw Orthopedic, Inc. Highly compression resistant matrix with porous skeleton
US20110208190A1 (en) * 2010-02-23 2011-08-25 University Of Connecticut Natural Polymer-Based Porous Orthopedic Fixation Screw for Bone Repair and Regeneration
JP5512887B2 (en) 2011-05-13 2014-06-04 学校法人北里研究所 Growth factor anchor ring-shaped bone graft material and growth factor anchor ring-shaped bone graft material for the production of a kit
CN103800099B (en) * 2012-11-05 2016-03-30 远东新世纪股份有限公司 Porous bone filling material
US9827268B2 (en) * 2013-08-06 2017-11-28 Kuraray Noritake Dental Inc. Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials
US9486483B2 (en) 2013-10-18 2016-11-08 Globus Medical, Inc. Bone grafts including osteogenic stem cells, and methods relating to the same
US9539286B2 (en) 2013-10-18 2017-01-10 Globus Medical, Inc. Bone grafts including osteogenic stem cells, and methods relating to the same
US9463264B2 (en) 2014-02-11 2016-10-11 Globus Medical, Inc. Bone grafts and methods of making and using bone grafts
US9539363B2 (en) 2014-04-24 2017-01-10 Warsaw Orthopedic, Inc. Collagen matrix

Citations (193)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180605B2 (en)
US3949073A (en) 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US3968567A (en) 1975-04-21 1976-07-13 Nevins Alan J Endodontic composition and method
US4131597A (en) 1975-01-17 1978-12-26 Ernst Leitz Gmbh Bioactive composite material process of producing and method of using same
US4191747A (en) 1976-12-17 1980-03-04 Hans Scheicher Corrective agent for the covering and/or filling of bone defects, method for the preparation of same and method of using the same
US4192021A (en) 1976-05-12 1980-03-11 Batelle-Institut e.V. Bone replacement or prosthesis anchoring material
US4202055A (en) 1976-05-12 1980-05-13 Battelle-Institut E.V. Anchorage for highly stressed endoprostheses
US4233360A (en) 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4237559A (en) 1979-05-11 1980-12-09 General Electric Company Bone implant embodying a composite high and low density fired ceramic construction
US4356572A (en) 1979-07-12 1982-11-02 Etablissement Public Dit: Agence Nationale De Valorisation De La Recherche (Anvar) Biodegradable implant useable as a bone prosthesis
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4412947A (en) 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4429691A (en) 1979-10-08 1984-02-07 Mitsubishi Mining And Cement Company, Ltd. Method for filling in defects or hollow portions of bones
EP0164483A1 (en) 1984-06-12 1985-12-18 Oscobal Ag Method of producing a bone replacement material
US4563350A (en) 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US4596574A (en) 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US4606910A (en) 1984-06-28 1986-08-19 Interface Biomedical Laboratories Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same
EP0197693A2 (en) 1985-03-28 1986-10-15 COLLAGEN CORPORATION (a Delaware corporation) Xenogeneic collagen/mineral preparations in bone repair
US4619655A (en) 1984-01-26 1986-10-28 University Of North Carolina Plaster of Paris as a bioresorbable scaffold in implants for bone repair
US4620327A (en) 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction
US4629464A (en) 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute
US4642120A (en) 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones
US4668295A (en) 1985-04-25 1987-05-26 University Of Dayton Surgical cements
US4693986A (en) 1985-06-25 1987-09-15 Orthomatrix, Inc. Ceramic process and products
US4698326A (en) 1985-12-20 1987-10-06 Regents Of The University Of Minnesota Composition and method for osseous repair
EP0243178A2 (en) 1986-04-22 1987-10-28 Collagen Corporation A marrow/collagen/mineral matrix for bone defect repair
US4774227A (en) 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
US4776890A (en) 1985-12-18 1988-10-11 Collagen Corporation Preparation of collagen hydroxyapatite matrix for bone repair
US4780450A (en) 1985-12-20 1988-10-25 The University Of Maryland At Baltimore Physically stable composition and method of use thereof for osseous repair
US4789663A (en) 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
US4843112A (en) 1987-03-12 1989-06-27 The Beth Israel Hospital Association Bioerodable implant composition
US4846838A (en) 1983-07-15 1989-07-11 Tdk Corporation Prosthetic body for bone substitute and a method for the preparation thereof
US4863732A (en) 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
US4863856A (en) 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
US4888366A (en) 1984-10-24 1989-12-19 Collagen Corporation Inductive collagen-based bone repair preparations
US4891359A (en) 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
WO1990000892A1 (en) 1988-07-23 1990-02-08 Nitta Gelatin Inc. Hardening material for medical and dental use
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US4970298A (en) 1984-03-27 1990-11-13 University Of Medicine And Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4992226A (en) 1985-03-28 1991-02-12 Collagen Corporation Method of making molds with xenogeneic collagen/mineral preparations for bone repair
US5001169A (en) 1984-10-24 1991-03-19 Collagen Corporation Inductive collagen-based bone repair preparations
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5035715A (en) 1986-11-06 1991-07-30 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US5053212A (en) 1988-04-20 1991-10-01 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US5073373A (en) 1989-09-21 1991-12-17 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
EP0271668B1 (en) 1986-10-22 1991-12-18 Gesellschaft für Biotechnologische Forschung mbH (GBF) Growth stimulating material, process for its production, and therapeutic composition
US5085861A (en) 1987-03-12 1992-02-04 The Beth Israel Hospital Association Bioerodable implant composition comprising crosslinked biodegradable polyesters
US5137534A (en) 1988-01-11 1992-08-11 Asahi Kogaku Kogyo K.K. Method for producing dental and medical bone prosthesis and bone prosthesis produced thereby
US5152836A (en) 1990-09-27 1992-10-06 Mitsubishi Materials Corporation Hydraulic calcium phosphate cement composition and cement composition containing hardening liquid
US5162114A (en) 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5171574A (en) 1989-02-23 1992-12-15 Stryker Corporation Bone collagen matrix for implants
EP0522569A1 (en) 1991-07-12 1993-01-13 United States Surgical Corporation Composition for effecting bone repair
US5204382A (en) 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US5207710A (en) 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
WO1993012736A1 (en) 1991-12-30 1993-07-08 Norian Corporation Mineralized collagen
US5231169A (en) 1990-10-17 1993-07-27 Norian Corporation Mineralized collagen
US5236704A (en) 1988-01-28 1993-08-17 Sumitomo Pharmaceuticals Co., Ltd. Controlled release formulation
US5246457A (en) 1985-03-28 1993-09-21 Collagen Corporation Xenogeneic collagen/mineral preparations in bone repair
US5258029A (en) 1988-09-29 1993-11-02 Collagen Corporation Method for improving implant fixation
US5262166A (en) 1991-04-17 1993-11-16 Lty Medical Inc Resorbable bioactive phosphate containing cements
US5304577A (en) 1991-05-01 1994-04-19 Onoda Cement Co., Ltd. Medical or dental hardening compositions
US5306303A (en) 1991-11-19 1994-04-26 The Medical College Of Wisconsin, Inc. Bone induction method
US5320844A (en) 1992-03-12 1994-06-14 Liu Sung Tsuen Composite materials for hard tissue replacement
US5338772A (en) 1991-06-20 1994-08-16 Merck Patent Gesellschaft Mit Beschrankter Haftung Implant material
US5352715A (en) 1992-02-28 1994-10-04 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5366508A (en) 1986-01-28 1994-11-22 Thm Biomedical, Inc Apparatus for biodegradable, osteogenic, bone graft substitute device
US5399361A (en) 1992-05-01 1995-03-21 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
US5422340A (en) 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5433751A (en) 1992-04-03 1995-07-18 Inoteb Bone prosthesis material containing calcium carbonate particles dispersed in a bioresorbable polymer matrix
US5443531A (en) 1991-04-29 1995-08-22 South African Medical Research Council Delivery system for biologically active growth or morphogenetic factors and to a method for preparing such a delivery system
US5508267A (en) 1991-10-22 1996-04-16 Isis Innovation Limited Bioactive material
US5522893A (en) 1993-03-12 1996-06-04 American Dental Association Health Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
US5522894A (en) 1984-12-14 1996-06-04 Draenert; Klaus Bone replacement material made of absorbable beads
US5531791A (en) 1993-07-23 1996-07-02 Bioscience Consultants Composition for repair of defects in osseous tissues, method of making, and prosthesis
US5532217A (en) 1992-04-24 1996-07-02 Silver; Frederick H. Process for the mineralization of collagen fibers, product produced thereby and use thereof to repair bone
US5549671A (en) * 1994-12-28 1996-08-27 Mcghan Medical Corporation Adjunctive filler material for fluid-filled prosthesis
EP0429438B1 (en) 1984-07-06 1996-08-28 Collagen Corporation Bone repair using collagen
US5552454A (en) 1988-08-09 1996-09-03 Henkel Kommanditgesellschaft Auf Aktien New materials for bone replacement and for joining bones or prostheses
US5573771A (en) 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
EP0747067A2 (en) 1995-06-07 1996-12-11 Collagen Corporation Moldable collagen compositions for hard tissue repair and augmentation
WO1996039203A1 (en) 1995-06-06 1996-12-12 Gensci Regeneration Laboratories, Inc. Modified osteogenic materials
US5618339A (en) 1995-07-20 1997-04-08 Matsumoto Dental College Osteoinduction substance, method of manufacturing the same, and bone filling material including the same
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5650176A (en) 1995-05-19 1997-07-22 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US5677284A (en) 1995-06-06 1997-10-14 Regen Biologics, Inc. Charged collagen particle-based delivery matrix
US5681873A (en) 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5707962A (en) 1994-09-28 1998-01-13 Gensci Regeneration Sciences Inc. Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
US5709934A (en) 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US5711957A (en) 1993-05-13 1998-01-27 Inoteb Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable implant
US5741329A (en) 1994-12-21 1998-04-21 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US5755792A (en) 1986-01-28 1998-05-26 Thm Biomedical, Inc. Method and apparatus for biodegradable, osteogenic, bone graft substitute device
US5769897A (en) 1991-12-13 1998-06-23 Haerle; Anton Synthetic bone
US5776193A (en) 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
WO1998040113A1 (en) 1997-03-13 1998-09-17 University Of Florida Tissue Bank, Inc. Bone paste
US5824087A (en) 1994-04-11 1998-10-20 Aberdeen University And Plasma Biotal Limited Bone regeneration
US5830493A (en) 1994-09-30 1998-11-03 Yamanouchi Pharmaceutical Co., Ltd. Bone-forming graft
US5837752A (en) 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US5846312A (en) 1994-08-23 1998-12-08 Norian Corporation Storage stable calcium phosphate cements
US5904718A (en) 1986-03-27 1999-05-18 Biocoll Laboratories, Inc. Delayed drug delivery system
US5910315A (en) 1997-07-18 1999-06-08 Stevenson; Sharon Allograft tissue material for filling spinal fusion cages or related surgical spaces
US5932207A (en) 1989-11-03 1999-08-03 Schmidt; Karlheinz Complex active ingredient for the production of biological parts, especially organs for living organisms: method for the production of the same and its use
US5948426A (en) 1997-05-03 1999-09-07 Jefferies; Steven R. Method and article to induce hematopoietic expansion
US5952010A (en) 1988-04-20 1999-09-14 Norian Corporation Paste compositions capable of setting into carbonated apatite
US5955438A (en) 1994-07-19 1999-09-21 Colbar R & D Ltd. Collagen-based matrix
US5958430A (en) 1998-02-20 1999-09-28 Battelle Memorial Institute Thin film composition with biological substance and method of making
US5964805A (en) 1997-02-12 1999-10-12 Stone; Kevin R. Method and paste for articular cartilage transplantation
US5990381A (en) 1996-11-13 1999-11-23 Ise International, Co., Ltd. Biomedical materials
US5997895A (en) 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6013856A (en) 1995-06-07 2000-01-11 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US6037519A (en) 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
US6118043A (en) 1991-06-26 2000-09-12 Merck Patent Gesellschaft Mit Beschrankter Haftung Bone replacement material with FGF
US6123731A (en) 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US6136029A (en) 1997-10-01 2000-10-24 Phillips-Origen Ceramic Technology, Llc Bone substitute materials
US6136030A (en) 1999-01-12 2000-10-24 Purzer Pharmaceutical Co., Ltd. Process for preparing porous bioceramic materials
EP1053739A1 (en) 1999-05-18 2000-11-22 Matsumoto Dental University Method of manufacturing an osteoconductive substance
EP0901795A3 (en) 1997-09-11 2000-11-29 JOHNSON &amp; JOHNSON MEDICAL, INC. Buffered wound dressing materials
US6165487A (en) 1996-09-30 2000-12-26 Children's Medical Center Corporation Methods and compositions for programming an organic matrix for remodeling into a target tissue
US6180606B1 (en) 1994-09-28 2001-01-30 Gensci Orthobiologics, Inc. Compositions with enhanced osteogenic potential, methods for making the same and uses thereof
US6183515B1 (en) 1994-08-08 2001-02-06 Board Of Regents, The University Of Texas System Artificial bone implants
US6187046B1 (en) 1997-03-14 2001-02-13 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone material and process for the production of the same
US6187329B1 (en) 1997-12-23 2001-02-13 Board Of Regents Of The University Of Texas System Variable permeability bone implants, methods for their preparation and use
US6203573B1 (en) 1995-10-11 2001-03-20 Osteobiologics, Inc. Method of making biodegradable implant material and products made therefrom
US6203574B1 (en) 1998-04-14 2001-03-20 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone filler and process for the production of the same
US20010014667A1 (en) 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20010014831A1 (en) 1998-12-14 2001-08-16 Scarborough Nelson L. Bone graft, method of making bone graft and guided bone regeneration method
US20010014830A1 (en) 1995-10-16 2001-08-16 Orquest, California Corporation Bone grafting matrix
US20010014662A1 (en) 1997-03-20 2001-08-16 David C Rueger Improved osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US20010016772A1 (en) 1997-03-07 2001-08-23 Lee David A. Tissue implant
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US6281195B1 (en) 1997-02-07 2001-08-28 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US20010018614A1 (en) 1999-03-16 2001-08-30 Bianchi John R. Implants for orthopedic applications
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US6300315B1 (en) 1999-08-28 2001-10-09 Ceramedical, Inc. Mineralized collagen membrane and method of making same
US20010031799A1 (en) 1999-12-28 2001-10-18 Shimp Lawrence A. Calcium phosphate bone graft material, process for making same and osteoimplant fabricated from same
US6309422B1 (en) 1997-06-20 2001-10-30 Alfred Farrington Bone grafting material
US6311690B1 (en) 1986-03-27 2001-11-06 Gensci Orthobiologics, Inc. Bone repair material and delayed drug delivery system
US20010041792A1 (en) 2000-02-03 2001-11-15 Donda Russell S. Extraction of growth factors from tissue
US6326018B1 (en) 1998-02-27 2001-12-04 Musculoskeletal Transplant Foundation Flexible sheet of demineralized bone
US20010051834A1 (en) 1999-03-24 2001-12-13 Chondros, Inc. Method for composite cell-based implants
US20010053937A1 (en) 1997-10-01 2001-12-20 Johnson James R. Bone substitutes
US6340648B1 (en) 1999-04-13 2002-01-22 Toshiba Ceramics Co., Ltd. Calcium phosphate porous sintered body and production thereof
US20020013626A1 (en) 2000-07-19 2002-01-31 Peter Geistlich Bone material and collagen combination for repair of injured joints
US20020018798A1 (en) 2000-06-21 2002-02-14 Merck Patent Gesellschaft Mit Beschrankter Haftung Coating for metallic implant materials
US20020018797A1 (en) 2000-05-19 2002-02-14 Fuzhai Cui Nano-calcium phosphates/collagen based bone substitute materials
US20020018796A1 (en) 1998-01-28 2002-02-14 John F. Wironen Thermally sterilized bone paste
US20020022885A1 (en) 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
US20020022883A1 (en) 2000-06-13 2002-02-21 Burg Karen J.L. Tissue engineering composite
US20020034532A1 (en) 1996-12-20 2002-03-21 Brodbeck Kevin J. Injectable depot gel composition and method of preparing the composition
US20020042657A1 (en) 1995-09-01 2002-04-11 Millenium Biologix, Inc. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6384197B1 (en) 1998-03-24 2002-05-07 Merck Patent Gesellschaft Process for the preparation of mineralized collagen fibrils and their use as bone substitute material
US6384196B1 (en) 1998-03-24 2002-05-07 Merck Patent Gesellschaft Process for the preparation of mineralized collagen fibrils and their uses as bone substitute material
US20020054901A1 (en) 1999-03-02 2002-05-09 Gainey Glenn Morris Methods and compositions for bone graft implants
US20020055143A1 (en) 1998-08-07 2002-05-09 Tissue Engineering, Inc. Bone precursor compositions
US6395036B1 (en) 1998-04-06 2002-05-28 Isis Innovation Limited Composite material and methods of making the same
US20020082594A1 (en) 1999-10-02 2002-06-27 Cary Hata Injectable biomaterial and methods for use thereof
US20020082694A1 (en) 1999-02-04 2002-06-27 Mckay William F. Highly-mineralized osteogenic sponge compositions, and uses thereof
US20020082697A1 (en) 2000-12-22 2002-06-27 Damien Christopher J. Implantable osteogenic material
US6425949B1 (en) 1997-10-07 2002-07-30 Dr. H. C. Robert Mathys Stiftung Hydraulic surgical cement
US20020128722A1 (en) 1987-07-30 2002-09-12 Steven R. Jefferies Bone repair material and delayed drug delivery system
US6479565B1 (en) 1999-08-16 2002-11-12 Harold R. Stanley Bioactive ceramic cement
US6511510B1 (en) 1998-09-15 2003-01-28 Isotis N.V. Osteoinductive ceramic materials
US6524345B1 (en) 1996-10-25 2003-02-25 Bionx Implants Oy Surgical implant
US20030152606A1 (en) 2000-01-28 2003-08-14 Thomas Gerber Inorganic resorbable bone substitute material and production method
WO2003092759A1 (en) 2002-05-01 2003-11-13 Japan Science And Technology Agency Method for preparing porous composite material
US20030232071A1 (en) 2002-04-18 2003-12-18 Gower Laurie B. Biomimetic organic/inorganic composites, processes for their production, and methods of use
US20040131562A1 (en) 2002-04-18 2004-07-08 Gower Laurie B. Biomimetic organic/inorganic composites, processes for their production, and methods of use
EP1437148A1 (en) 2001-10-19 2004-07-14 Japan Science and Technology Agency Organic/inorganic composite biomaterials and processes for producing the same
WO2004078120A2 (en) 2003-02-28 2004-09-16 Fibrogen, Inc. Collagen compositions and biomaterials
WO2004103422A1 (en) 2003-05-26 2004-12-02 Pentax Corporation Porous composite containing calcium phosphate and process for producing the same
US6846327B2 (en) * 2001-05-01 2005-01-25 Amedica Corporation Radiolucent bone graft
US20050089579A1 (en) 2003-09-12 2005-04-28 Rebecca Li Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
US6903146B2 (en) 2001-05-02 2005-06-07 Pentax Corporation Prosthetic filler for a living body and method of manufacturing the prosthetic filler
WO2005051447A1 (en) 2003-10-28 2005-06-09 Cambridge University Technical Services Limited Composite biomaterials comprising calcium phospate materials, collagen and glycosaminoglycans
EP1127581B1 (en) 1998-02-27 2005-06-15 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
WO2005081699A2 (en) 2003-04-18 2005-09-09 University Of Florida Biomimetic organic/inorganic composites, processes for their production, and methods of use
US20050199156A1 (en) 2004-02-10 2005-09-15 Ibrahim Khairoun Macroporous, resorbable and injectible calcium phosphate-based cements (MCPC) for bone repair, augmentation, regeneration, and osteoporosis treatment
US20050217538A1 (en) 2004-03-31 2005-10-06 Technische Universitat Dresden Modified Calcium Phosphate Bone Cement
WO2005099785A1 (en) 2004-04-15 2005-10-27 Nexilis Ag Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix
WO2006031196A1 (en) 2004-09-14 2006-03-23 Agency For Science, Technology And Research Porous biomaterial-filler composite and a method for making the same
US20060093670A1 (en) 2002-06-20 2006-05-04 Yutaka Mizushima Sustained-release composition process for producing the same and preparation thereof
WO2006092718A2 (en) 2005-03-04 2006-09-08 Fin-Ceramica Faenza S.P.A. Cartilaginiform and osteochondral sustitute comprising a multilayer structure and use thereof
US7105182B2 (en) 2001-07-25 2006-09-12 Szymaitis Dennis W Periodontal regeneration composition and method of using same
US20060246150A1 (en) 2000-12-22 2006-11-02 Thorne Kevin J Composition and Process for Bone Growth and Repair
US20060270037A1 (en) 2005-05-25 2006-11-30 Pentax Corporation Collagen-coated carrier and method for manufacturing collagen-coated carrier
US7153938B2 (en) 2002-11-06 2006-12-26 National Institute For Materials Science Cross-linked apatite/collagen porous body containing self-organized apatite/collagen composite and its production method
US7172629B2 (en) 1999-02-04 2007-02-06 Sdgi Holdings, Inc. Osteogenic paste compositions and uses thereof
US7189392B1 (en) 1999-10-15 2007-03-13 Genetics Institute, Llc Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins
WO2007053850A2 (en) 2005-11-01 2007-05-10 Osteotech, Inc. Bone matrix compositions and methods
US20080152687A1 (en) * 2006-12-21 2008-06-26 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof

Family Cites Families (334)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2471598A (en) 1945-12-03 1949-05-31 Goodrich Co B F Tool for installing hollow rivets
US3368911A (en) 1965-03-25 1968-02-13 Ethicon Inc Collagen-carbonic acid surgical sponge
US3393080A (en) 1965-10-20 1968-07-16 Fmc Corp Microcrystalline colloidal collagen dispersions in dispersing media containing dimethyl sulfoxide and water-miscible organic solvents
US3471598A (en) 1966-02-14 1969-10-07 Fmc Corp Method of producing absorbent mats
US3443261A (en) 1967-09-01 1969-05-13 Fmc Corp Prosthetic structures from microcrystalline collagen
US3767437A (en) 1971-10-20 1973-10-23 Avicon Inc Phosthetic structures derived from collagen
US3919723A (en) 1974-05-20 1975-11-18 Friedrichsfeld Gmbh Bone shaft or bone joint prosthesis and process
JPS5839533B2 (en) 1975-12-30 1983-08-30 Sumitomo Chemical Co
US4066083A (en) 1976-06-03 1978-01-03 Pentapharm A.G. Sterile surgical collagen product
US4440680A (en) 1980-09-24 1984-04-03 Seton Company Macromolecular biologically active collagen articles
JPS6052129B2 (en) 1979-10-04 1985-11-18 Kureha Chemical Ind Co Ltd
WO1981000963A1 (en) 1979-10-08 1981-04-16 Pentapharm Ag Process for preparing a collagen product for medical and cosmetic use
DE2967060D1 (en) 1979-12-18 1984-07-19 Oscobal Ag Bone replacement material and process for producing a bone replacement material
US4789732A (en) 1980-08-04 1988-12-06 Regents Of The University Of California Bone morphogenetic protein composition
US4294753A (en) 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4795804A (en) 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
US4455256A (en) 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4619989A (en) 1981-05-05 1986-10-28 The Regents Of The University Of Cal. Bone morphogenetic protein composition
US4472840A (en) 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
FR2517315B1 (en) 1981-11-30 1985-12-20 Tech Cuir Centre Process for the preparation of new forms of collagen, native or decrosslinked, a helical structure preserved, has associated mucopolysaccharides and their applications especially in Facial care, pharmaceutical, analytical and other
US4430760A (en) 1981-12-18 1984-02-14 Collagen Corporation Nonstress-bearing implantable bone prosthesis
US4440750A (en) 1982-02-12 1984-04-03 Collagen Corporation Osteogenic composition and method
US4485097A (en) 1982-05-26 1984-11-27 Massachusetts Institute Of Technology Bone-equivalent and method for preparation thereof
US4804744A (en) 1984-01-04 1989-02-14 International Genetic Engineering, Inc. Osteogenic factors
US4563489A (en) 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4609551A (en) 1984-03-20 1986-09-02 Arnold Caplan Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites
JPH0575425B2 (en) 1984-05-28 1993-10-20 Kyocera Corp
DE3588058T3 (en) 1984-07-16 2005-04-07 Celtrix Pharmaceuticals, Inc., Palo Alto Cartilage-inducing polypeptide factors from bone
USRE35694E (en) 1984-07-16 1997-12-16 Celtrix Pharmaceuticals, Inc. Polypeptide cartilage-inducing factors found in bone
US4843063A (en) 1984-07-16 1989-06-27 Collagen Corporation Polypeptide cartilage-inducing factors found in bone
US4557764A (en) 1984-09-05 1985-12-10 Collagen Corporation Process for preparing malleable collagen and the product thereof
US4637931A (en) 1984-10-09 1987-01-20 The United States Of America As Represented By The Secretary Of The Army Polyactic-polyglycolic acid copolymer combined with decalcified freeze-dried bone for use as a bone repair material
US4600533A (en) 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US4656130A (en) 1985-03-14 1987-04-07 Yissum Research Development Company Collagen coated cell growth plates
EP0198213B1 (en) 1985-03-15 1990-08-08 Yeda Research And Development Company, Ltd. Method and compositions comprising a vitamin d derivative for the local treatment of bone fractures
US5273964A (en) 1985-03-20 1993-12-28 Lemons J E Inorganic and organic composition for treatment of bone lesions
JPH0662679B2 (en) 1985-06-21 1994-08-17 新田ゼラチン株式会社 Organization affinity Korah - Gen and its manufacturing method
FR2585576B1 (en) 1985-07-30 1992-01-03 Bioetica Sa substitute bone matrix osteogenesis promoting
US5904717A (en) 1986-01-28 1999-05-18 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US6005161A (en) 1986-01-28 1999-12-21 Thm Biomedical, Inc. Method and device for reconstruction of articular cartilage
US4839215A (en) 1986-06-09 1989-06-13 Ceramed Corporation Biocompatible particles and cloth-like article made therefrom
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US6432919B1 (en) 1986-07-01 2002-08-13 Genetics Institute, Inc. Bone morphogenetic protein-3 and compositions
US5543394A (en) 1986-07-01 1996-08-06 Genetics Institute, Inc. Bone morphogenetic protein 5(BMP-5) compositions
FR2601593B1 (en) 1986-07-16 1994-04-15 Cellulose Pin hydrophilic biocompatible material, manufacturing process and applications
US4743229A (en) 1986-09-29 1988-05-10 Collagen Corporation Collagen/mineral mixing device and method
FI80605C (en) 1986-11-03 1990-07-10 Biocon Oy Benkirurgisk biokompositmaterial.
US4919670A (en) 1988-02-03 1990-04-24 Intermedics Orthopedics, Inc. Modular humeral prosthesis
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
ES2060614T3 (en) 1988-03-11 1994-12-01 Chemokol G B R Ing Buro Fur Ko Process for the manufacture of collagen membranes for hemostasis, wound treatment and implants.
US5354557A (en) 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
US5344654A (en) 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
CA1341610C (en) 1988-04-08 2011-02-01 Creative Biomolecules, Inc. Osteogenic polypeptides
US5108753A (en) 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5250302A (en) 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US4880610A (en) 1988-04-20 1989-11-14 Norian Corporation In situ calcium phosphate minerals--method and composition
US5047031A (en) 1988-04-20 1991-09-10 Norian Corporation In situ calcium phosphate minerals method
GB8813033D0 (en) 1988-06-02 1988-07-06 Geistlich Soehne Ag Chemical compound
EP0349048A3 (en) 1988-06-27 1990-07-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth factors derived from regenerating bone marrow
US5110604A (en) 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US4948540A (en) 1988-08-01 1990-08-14 Semex Medical, Inc. Method of preparing collagen dressing sheet material
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
US5108436A (en) 1988-09-29 1992-04-28 Collagen Corporation Implant fixation
US5306500A (en) 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5475052A (en) 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
GB8827986D0 (en) 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
US5034059A (en) 1989-02-17 1991-07-23 Norian Corporation Composition comprising octacalcium phosphate crystals and polypeptide
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5061286A (en) 1989-08-18 1991-10-29 Osteotech, Inc. Osteoprosthetic implant
US5158934A (en) 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US4997446A (en) 1989-09-14 1991-03-05 Intermedics Orthopedics, Inc. Method and apparatus for osseous contour reconstruction
US5290558A (en) 1989-09-21 1994-03-01 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5916553A (en) 1992-09-17 1999-06-29 Schmidt; Karlheinz Complex for inducing bone growth in the mastoid cavity
US5236456A (en) 1989-11-09 1993-08-17 Osteotech, Inc. Osteogenic composition and implant containing same
EP0439689B1 (en) 1990-01-04 1994-12-21 L.B. BOHLE PHARMATECHNIK GmbH Mixgranulator
US5071655A (en) 1990-01-12 1991-12-10 Baylink David J Pharmaceutical combination for treatment of bone-wasting diseases
US5492697A (en) 1990-03-05 1996-02-20 Board Of Regents, Univ. Of Texas System Biodegradable implant for fracture nonunions
US5290494A (en) 1990-03-05 1994-03-01 Board Of Regents, The University Of Texas System Process of making a resorbable implantation device
US5164187A (en) 1990-04-05 1992-11-17 Norian Corporation Hydroxyapatite prosthesis coatings
JP2978203B2 (en) 1990-04-20 1999-11-15 日本特殊陶業株式会社 Method of manufacturing a ceramic body having a bioactive surface layer
US5274078A (en) 1990-08-08 1993-12-28 Showa Denko K.K. Process for producing collagen powder
US5263985A (en) 1990-08-14 1993-11-23 Pfizer Hospital Products Group, Inc. Bone growth stimulator
DE69120177T2 (en) 1990-09-10 1996-10-10 Synthes Ag Membrane for bone regeneration
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
CA2071912C (en) 1990-11-30 2002-10-15 Hanne Bentz Use of a bone morphogenetic protein in synergistic combination with tgf-beta for bone repair
US5206023A (en) 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
US5208219A (en) 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
US5169837A (en) 1991-03-28 1992-12-08 Allelix Biopharmaceuticals Inc. Isolated osteogenic factor
JP2774695B2 (en) 1991-03-29 1998-07-09 コラーゲン コーポレイション Apparatus and method for treatment of facial wrinkles
US5563124A (en) 1991-04-22 1996-10-08 Intermedics Orthopedics/ Denver, Inc. Osteogenic product and process
US5290763A (en) 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
DE69228118D1 (en) 1991-06-25 1999-02-18 Genetics Inst BMP 9 compositions
US6287816B1 (en) 1991-06-25 2001-09-11 Genetics Institute, Inc. BMP-9 compositions
CA2071137A1 (en) 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5270300A (en) 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
US5171579A (en) 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
WO1993013815A1 (en) 1992-01-13 1993-07-22 Lucocer Aktiebolag An implant
US5314476A (en) 1992-02-04 1994-05-24 Osteotech, Inc. Demineralized bone particles and flowable osteogenic composition containing same
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
GB9206509D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
CA2093836A1 (en) 1992-04-24 1993-10-25 Wayne Gombotz Biodegradable tgf-.beta. delivery system for bone regeneration
US5366756A (en) 1992-06-15 1994-11-22 United States Surgical Corporation Method for treating bioabsorbable implant material
US5428022A (en) 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
JP3289393B2 (en) 1992-09-18 2002-06-04 ソニー株式会社 Charging system for video camera
DE4242889A1 (en) 1992-12-18 1994-06-23 Merck Patent Gmbh Hohlendoprothesen with bone growth-promoting filling
DE4244466C2 (en) 1992-12-24 1995-02-23 Pharmatech Gmbh A process for the production of pseudolatices and micro- or nanoparticles and their use for the production of pharmaceutical preparations
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
FR2702757B1 (en) 1993-03-17 1995-06-16 Rhone Poulenc Chimie New aluminum phosphate, process for its preparation and its use in the preparation of materials comprising a binder and ceramic parts.
US5565502A (en) 1993-03-24 1996-10-15 Children's Medical Center Corporation Isolation of the calcium-phosphate crystals of bone
CA2119090A1 (en) 1993-03-26 1994-09-27 Wayne R. Gombotz Compositions for controlled release of biologically active tgf-.beta.
CA2121192A1 (en) 1993-04-21 1994-10-22 Kiminori Atsumi Collagen membranes
US5637480A (en) 1993-05-12 1997-06-10 Genetics Institute, Inc. DNA molecules encoding bone morphogenetic protein-10
FR2705235B1 (en) 1993-05-13 1995-07-13 Inoteb Use of particles of a biocompatible and bioabsorbable calcium salt as active ingredient in the preparation of a medicament for the local treatment of demineralizing bone diseases.
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
US5426769A (en) 1993-08-26 1995-06-20 Metalink Corp. System and method for producing input/output expansion for single chip microcomputers
ES2265146T3 (en) 1993-08-26 2007-02-01 Genetics Institute, Llc human bone morphogenetic proteins for use in nerve regeneration.
WO1995008304A1 (en) 1993-09-21 1995-03-30 The Penn State Research Foundation Bone substitute composition comprising hydroxyapatite and a method of production therefor
US5736160A (en) 1993-10-28 1998-04-07 Thm Biomedical, Inc. Process and device for treating and healing a bone void
US5507813A (en) 1993-12-09 1996-04-16 Osteotech, Inc. Shaped materials derived from elongate bone particles
DE9402499U1 (en) 1994-02-16 1994-07-14 Bohle L B Pharmatech Gmbh agitator
CA2142209A1 (en) 1994-03-29 1995-09-30 George H. Chu Collagen implants having improved tensile properties
US7963997B2 (en) 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
US20020032488A1 (en) 1994-05-13 2002-03-14 Brekke John H. Device for regeneration of articular cartilage and other tissue
US5981825A (en) 1994-05-13 1999-11-09 Thm Biomedical, Inc. Device and methods for in vivo culturing of diverse tissue cells
DE69527957D1 (en) 1994-05-24 2002-10-02 Implico Bv Biomaterial and implant for repair and replacement of bone
US5906827A (en) 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
US5547378A (en) 1994-10-21 1996-08-20 Linkow; Leonard I. Apparatus and method for closing a sinus opening during a dental implant operation
CA2164045A1 (en) 1994-11-30 1996-05-31 Kevin Cooper Hard tissue bone cements and substitutes
US5928635A (en) 1994-12-07 1999-07-27 Schmidt; Karlheinz Process for producing active agent complexes
JP3450920B2 (en) 1994-12-26 2003-09-29 京セラ株式会社 Method of manufacturing bioprosthetic member
CA2186616A1 (en) 1995-02-02 1996-08-08 Anjun Liu Completely dissolved bone tissue and method for producing the same
US6371985B1 (en) 1995-03-09 2002-04-16 Robert S. Goldberg Prostheses restrained by immediate attachment while ingrowth proceeds naturally over time
US5674290A (en) 1995-04-05 1997-10-07 Li; Shu-Tung Water-stabilized biopolymeric implants
US5733337A (en) 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5750146A (en) 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
US7517539B1 (en) 1996-10-16 2009-04-14 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
US6953594B2 (en) 1996-10-10 2005-10-11 Etex Corporation Method of preparing a poorly crystalline calcium phosphate and methods of its use
CN1133462C (en) 1995-06-05 2004-01-07 遗传学研究所有限责任公司 Methods and compositions for healing and repair of connective tissue attachment
US5910492A (en) 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
US6352972B1 (en) 1995-06-06 2002-03-05 Marcel E. Nimni Bone morphogenetic proteins and their use in bone growth
US6039762A (en) 1995-06-07 2000-03-21 Sdgi Holdings, Inc. Reinforced bone graft substitutes
US6423095B1 (en) 1995-10-16 2002-07-23 Sdgi Holdings, Inc. Intervertebral spacers
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
DE69733292T2 (en) 1996-03-01 2006-04-27 Isotis N.V. A method for in vitro production of bone
US6261565B1 (en) 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6299905B1 (en) 1996-04-16 2001-10-09 Depuy Orthopaedics, Inc. Bioerodable polymeric adhesives for tissue repair
FR2749756B1 (en) 1996-06-14 1998-09-11 Bioland Method of preparing an implantable composite material, material obtained implant material comprising this and implementation kit
US5824084A (en) 1996-07-03 1998-10-20 The Cleveland Clinic Foundation Method of preparing a composite bone graft
JPH1033657A (en) 1996-07-23 1998-02-10 Dainippon Ink & Chem Inc In vivo decomposing material and its manufacture
US5964807A (en) 1996-08-08 1999-10-12 Trustees Of The University Of Pennsylvania Compositions and methods for intervertebral disc reformation
ES2208974T3 (en) 1996-08-23 2004-06-16 Cook Biotech, Inc. Prosthetic grafts, materials and methods.
US6189537B1 (en) 1996-09-06 2001-02-20 Lifenet Process for producing osteoinductive bone, and osteoinductive bone produced thereby
US5676146B1 (en) 1996-09-13 2000-04-18 Osteotech Inc Surgical implant containing a resorbable radiopaque marker and method of locating such within a body
WO1998030252A1 (en) 1997-01-09 1998-07-16 Cohesion Technologies, Inc. Methods and apparatuses for making swellable uniformly shaped devices from polymeric materials
EP1844798A1 (en) 1997-02-13 2007-10-17 Zimmer Orthobiologics, Inc. Implantable putty material
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
WO1998035653A1 (en) 1997-02-13 1998-08-20 Benedict, James, A. Implantable collagen-containing putty material
US6679918B1 (en) 1997-02-13 2004-01-20 Centerpulse Biologics Inc. Implantable putty material
US6383810B2 (en) 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US5830340A (en) 1997-03-05 1998-11-03 Trumem International Llc Method for making a composite filter
US6071982A (en) 1997-04-18 2000-06-06 Cambridge Scientific, Inc. Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
EP0980272A1 (en) 1997-04-30 2000-02-23 Nobel Biocare AB Calcium-phosphate coated implant element
CN1264390A (en) 1997-05-28 2000-08-23 清水庆彦 Collagen gel
US6033438A (en) 1997-06-03 2000-03-07 Sdgi Holdings, Inc. Open intervertebral spacer
US5972368A (en) 1997-06-11 1999-10-26 Sdgi Holdings, Inc. Bone graft composites and spacers
US6123957A (en) 1997-07-16 2000-09-26 Jernberg; Gary R. Delivery of agents and method for regeneration of periodontal tissues
US6471993B1 (en) 1997-08-01 2002-10-29 Massachusetts Institute Of Technology Three-dimensional polymer matrices
US6090996A (en) 1997-08-04 2000-07-18 Collagen Matrix, Inc. Implant matrix
US6241771B1 (en) 1997-08-13 2001-06-05 Cambridge Scientific, Inc. Resorbable interbody spinal fusion devices
US6511958B1 (en) 1997-08-14 2003-01-28 Sulzer Biologics, Inc. Compositions for regeneration and repair of cartilage lesions
DE69714035D1 (en) 1997-08-14 2002-08-22 Sulzer Innotec Ag Composition and apparatus for the repair of cartilage tissue in vivo comprising nanocapsules with osteoinductive and / or chondroinductive factors
US7141072B2 (en) 1998-10-05 2006-11-28 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method for promoting regeneration of surface cartilage in a damaged joint using multi-layer covering
US6309420B1 (en) 1997-10-14 2001-10-30 Parallax Medical, Inc. Enhanced visibility materials for implantation in hard tissue
EP1030676B1 (en) 1997-10-30 2005-09-14 The General Hospital Corporation Bonding of cartilaginous matrices using isolated chondrocytes
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US5899939A (en) 1998-01-21 1999-05-04 Osteotech, Inc. Bone-derived implant for load-supporting applications
US20020076429A1 (en) 1998-01-28 2002-06-20 John F. Wironen Bone paste subjected to irradiative and thermal treatment
US7045141B2 (en) 1998-02-27 2006-05-16 Musculoskeletal Transplant Foundation Allograft bone composition having a gelatin binder
US20060204544A1 (en) 2002-05-20 2006-09-14 Musculoskeletal Transplant Foundation Allograft bone composition having a gelatin binder
US6432436B1 (en) 2000-10-03 2002-08-13 Musculoskeletal Transplant Foundation Partially demineralized cortical bone constructs
US6911212B2 (en) 1998-02-27 2005-06-28 Musculoskeletal Transplant Foundation Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
JP2000022044A (en) 1998-07-02 2000-01-21 Mitsubishi Electric Corp Semiconductor device and its manufacture
US6551355B1 (en) 1998-08-14 2003-04-22 Cambridge Scientific, Inc. Tissue transplant coated with biocompatible biodegradable polymer
US6406498B1 (en) 1998-09-04 2002-06-18 Bionx Implants Oy Bioactive, bioabsorbable surgical composite material
US6168801B1 (en) 1998-09-09 2001-01-02 Cardiac Pacemakers, Inc. Controlled release drug delivery
US6132468A (en) 1998-09-10 2000-10-17 Mansmann; Kevin A. Arthroscopic replacement of cartilage using flexible inflatable envelopes
EP0987031B1 (en) 1998-09-15 2003-04-02 IsoTis N.V. Method for coating medical implants
WO2001078798A1 (en) 2000-02-10 2001-10-25 Regeneration Technologies, Inc. Assembled implant
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
FI110062B (en) 1998-12-11 2002-11-29 Antti Yli-Urpo The new composite and its use
US6200347B1 (en) 1999-01-05 2001-03-13 Lifenet Composite bone graft, method of making and using same
US6214049B1 (en) 1999-01-14 2001-04-10 Comfort Biomedical, Inc. Method and apparatus for augmentating osteointegration of prosthetic implant devices
US6383519B1 (en) 1999-01-26 2002-05-07 Vita Special Purpose Corporation Inorganic shaped bodies and methods for their production and use
US6294187B1 (en) 1999-02-23 2001-09-25 Osteotech, Inc. Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US8133421B2 (en) 1999-02-23 2012-03-13 Warsaw Orthopedic, Inc. Methods of making shaped load-bearing osteoimplant
US20070233272A1 (en) 1999-02-23 2007-10-04 Boyce Todd M Shaped load-bearing osteoimplant and methods of making same
US6696073B2 (en) 1999-02-23 2004-02-24 Osteotech, Inc. Shaped load-bearing osteoimplant and methods of making same
JP2000262608A (en) 1999-03-12 2000-09-26 Mitsubishi Materials Corp Composite type bone packing material
US6205032B1 (en) 1999-03-16 2001-03-20 Cts Corporation Low temperature co-fired ceramic with improved registration
US6506217B1 (en) 1999-03-29 2003-01-14 Arnett Facial Reconstruction Courses, Inc. Moldable post-implantation bone filler and method
WO2000070018A3 (en) 1999-05-18 2001-08-30 Cryolife Inc Self-supporting, shaped, three-dimensional biopolymeric materials and methods
US6921412B1 (en) 1999-05-18 2005-07-26 Cryolife, Inc. Self-supporting, shaped, three-dimensional biopolymeric materials and methods
JP2003500112A (en) 1999-05-20 2003-01-07 ボストン・ユニバーシティ Anatomically accurate polymer-reinforced bioactive prostheses
US6251143B1 (en) 1999-06-04 2001-06-26 Depuy Orthopaedics, Inc. Cartilage repair unit
EP1203074A4 (en) 1999-06-29 2003-09-10 J Alexander Marchosky Compositions and methods for forming and strengthening bone
US6376211B1 (en) 1999-07-12 2002-04-23 Xoma Technology Ltd. Agents and methods for inhibiting F1/F0 ATPase
US6280191B1 (en) 1999-09-03 2001-08-28 Christopher B. Gordon Distractor suitable for permanent implantation into bone
US6221109B1 (en) 1999-09-15 2001-04-24 Ed. Geistlich Söhne AG fur Chemische Industrie Method of protecting spinal area
US6429748B2 (en) 1999-09-30 2002-08-06 Nortel Networks Limited Oscillation circuits featuring coaxial resonators
US6206924B1 (en) 1999-10-20 2001-03-27 Interpore Cross Internat Three-dimensional geometric bio-compatible porous engineered structure for use as a bone mass replacement or fusion augmentation device
DE19957388A1 (en) 1999-11-24 2001-06-13 Michael Sittinger Chondroinductive and Implantable substrates for cartilage healing and -protektion
WO2001039680A1 (en) 1999-11-30 2001-06-07 Bionx Implants, Oy Bioabsorbable, osteopromoting fixation plate
US20010044413A1 (en) 1999-12-01 2001-11-22 Glenn Pierce In situ bioreactors and methods of use thereof
DE60033055D1 (en) 1999-12-06 2007-03-08 Warsaw Orthopedic Inc Intervertebral disc treatment device
US20010037091A1 (en) 1999-12-29 2001-11-01 Wironen John F. System for reconstituting pastes and methods of using same
US6379385B1 (en) 2000-01-06 2002-04-30 Tutogen Medical Gmbh Implant of bone matter
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
FR2809412A1 (en) 2000-05-26 2001-11-30 Coletica Use of aquatic collagen for making supports for tissue engineering, particularly skin or tissue equivalents for surgical repair, studying aging processes and screening
GB2365234B (en) 2000-06-21 2004-03-31 Sgs Thomson Microelectronics Selective modification of clock pulses
KR100880622B1 (en) 2000-06-29 2003-04-07 바이오신텍 캐나다 인코포레이티드 Composition and method for the repair and regeneration of cartilage and other tissues
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US6479065B2 (en) 2000-08-10 2002-11-12 Alkermes Controlled Therapeutics, Inc. Process for the preparation of polymer-based sustained release compositions
US20020072804A1 (en) 2000-09-20 2002-06-13 Donda Russell S. Combination biological-non-biological material prosthetic implant and method
US7052517B2 (en) 2000-10-24 2006-05-30 Vita Special Purpose Corporation Delivery device for biological composites and method of preparation thereof
US6736799B1 (en) 2000-10-24 2004-05-18 Vita Licensing, Inc. Delivery device for biological composites and method of preparation thereof
US6547866B1 (en) 2000-10-30 2003-04-15 Howmedica Osteonics Corp. Porous calcium phosphate cement
US6576249B1 (en) 2000-11-13 2003-06-10 El Gendler Bone putty and method
US20020090725A1 (en) 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
US7192604B2 (en) 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
US6485709B2 (en) 2001-01-23 2002-11-26 Addent Inc. Dental bleaching gel composition, activator system and method for activating a dental bleaching gel
DE60115192T2 (en) 2001-02-26 2006-08-10 Ethicon, Inc. Biocompatible composite foam
EP1379287A1 (en) 2001-04-12 2004-01-14 Therics, Inc. Method and apparatus for engineered regenerative biostructures
US6444222B1 (en) 2001-05-08 2002-09-03 Verigen Transplantation Services International Ag Reinforced matrices
GB0115320D0 (en) 2001-06-22 2001-08-15 Univ Nottingham Matrix
JP4294474B2 (en) 2001-07-16 2009-07-15 デピュイ・プロダクツ・インコーポレイテッド Meniscal reproducing apparatus
JP2004535245A (en) 2001-07-16 2004-11-25 デピュイ・プロダクツ・インコーポレイテッド Porous extracellular matrix scaffold and Methods
EP1464345B1 (en) 2003-04-03 2009-12-30 Dennis W. Szymaitis Bone growth and adjacent tissue regeneration composition
CN1265845C (en) 2001-07-30 2006-07-26 株式会社日本组织工程 Tissue regenerating base material, implanting material and method of producing the same
US7132110B2 (en) 2001-08-30 2006-11-07 Isotis Orthobiologics, Inc. Tissue repair compositions and methods for their manufacture and use
JP4330991B2 (en) 2001-10-01 2009-09-16 スキャンディウス・バイオメディカル・インコーポレーテッド Apparatus and method for repairing defects in articular cartilage
JP2005505351A (en) 2001-10-12 2005-02-24 オステオテック インコーポレーテッド Improved bone graft
CA2463850C (en) 2001-10-18 2013-03-26 Lifecell Corporation Remodeling of tissues and organs
US6645250B2 (en) 2001-10-30 2003-11-11 Carl W. Schulter Biocompatible form and method of fabrication
US6478825B1 (en) 2001-11-28 2002-11-12 Osteotech, Inc. Implant, method of making same and use of the implant for the treatment of bone defects
US6840961B2 (en) 2001-12-21 2005-01-11 Etex Corporation Machinable preformed calcium phosphate bone substitute material implants
JP4624678B2 (en) 2002-02-21 2011-02-02 パイオニア・サージカル・オーソバイオロジックス,インコーポレイテッド Crosslinking bioactive hydrogel matrix
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
EP2295089A3 (en) 2002-07-31 2011-05-04 DENTSPLY International Inc. Bone repair putty comprising porous particulate and carrier gel
US7887831B2 (en) 2002-12-26 2011-02-15 Hepacore Ltd. Bone enhancing composite
US6884621B2 (en) 2002-12-23 2005-04-26 Industrial Technology Research Institute Method and carrier for culturing multi-layer tissue in vitro
EP1462126A1 (en) 2003-03-28 2004-09-29 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Improved Osteoinductive Materials
US8221781B2 (en) 2003-04-11 2012-07-17 Etex Corporation Osteoinductive bone material
WO2004098457A1 (en) 2003-04-30 2004-11-18 Therics, Inc. Bone void filler and method of manufacture
CA2519750A1 (en) 2003-05-28 2004-12-09 Blue Membranes Gmbh Implants with functionalized carbon surfaces
US7252685B2 (en) 2003-06-05 2007-08-07 Sdgi Holdings, Inc. Fusion implant and method of making same
WO2004110308A3 (en) 2003-06-11 2006-10-26 Osteotech Inc Osteoimplants and methods for their manufacture
US6974862B2 (en) 2003-06-20 2005-12-13 Kensey Nash Corporation High density fibrous polymers suitable for implant
US7494950B2 (en) 2003-09-05 2009-02-24 Synthes (U.S.A.) Bone cement compositions having fiber-reinforcement and/or increased flowability
US7163956B2 (en) * 2003-10-10 2007-01-16 C Sixty Inc. Substituted fullerene compositions and their use as antioxidants
US20050118230A1 (en) 2003-10-22 2005-06-02 Encelle, Inc. Methods and compositions for regenerating connective tissue
EP1701672A4 (en) 2003-12-19 2011-04-27 Osteotech Inc Tissue-derived mesh for orthopedic regeneration
US20070231788A1 (en) 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
US8328876B2 (en) 2003-12-31 2012-12-11 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
WO2005072656A1 (en) 2004-01-27 2005-08-11 Osteotech, Inc. Stabilized bone graft
US20050272153A1 (en) 2004-01-27 2005-12-08 Zou Xuenong Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
US7534264B2 (en) 2004-01-28 2009-05-19 Ultradent Products, Inc. Delivery system for bone growth promoting material
US7189263B2 (en) 2004-02-03 2007-03-13 Vita Special Purpose Corporation Biocompatible bone graft material
US20050175659A1 (en) 2004-02-09 2005-08-11 Macomber Laurel R. Collagen device and method of preparing the same
US8163030B2 (en) 2004-05-06 2012-04-24 Degradable Solutions Ag Biocompatible bone implant compositions and methods for repairing a bone defect
US7252841B2 (en) 2004-05-20 2007-08-07 Skeletal Kinetics, Llc Rapid setting calcium phosphate cements
DE102004030347B4 (en) 2004-06-18 2006-08-03 Aesculap Ag & Co. Kg implant
US9220595B2 (en) 2004-06-23 2015-12-29 Orthovita, Inc. Shapeable bone graft substitute and instruments for delivery thereof
JP4694163B2 (en) 2004-07-26 2011-06-08 株式会社ジーシー Method for producing a bioabsorbable granular porous bone filling material
WO2006010278A1 (en) 2004-07-26 2006-02-02 Synthes Gmbh Biocompatible, biodegradable polyurethane materials with controlled hydrophobic to hydrophilic ratio
US7175858B2 (en) 2004-07-26 2007-02-13 Skeletal Kinetics Llc Calcium phosphate cements and methods for using the same
US7722895B1 (en) 2004-09-20 2010-05-25 Warsaw Orthopedic, Inc. Osteogenic implants with combined implant materials, and materials and methods for same
US7670384B2 (en) 2004-10-14 2010-03-02 Biomet Manufacturing Corp. Bone graft composition comprising a bone material and a carrier comprising denatured demineralized bone
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
JP2008517660A (en) 2004-10-22 2008-05-29 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ Hollow and porous orthopedic or implant for use in dentistry to deliver biological agents
US7250550B2 (en) 2004-10-22 2007-07-31 Wright Medical Technology, Inc. Synthetic bone substitute material
DE102005034420A1 (en) 2004-12-23 2006-07-06 Ossacur Ag Gel-like material for the filling of bone and / or cartilage defects
KR20070104579A (en) 2004-12-30 2007-10-26 젠자임 코포레이션 Regimens for intra-articular viscosupplementation
US20060216321A1 (en) 2005-03-24 2006-09-28 Sdgi Holdings, Inc. Solvent based processing technologies for making tissue/polymer composites
US7621963B2 (en) 2005-04-13 2009-11-24 Ebi, Llc Composite bone graft material
WO2007032390A1 (en) 2005-09-13 2007-03-22 Takiron Co., Ltd. Composite porous material
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
US7498041B2 (en) 2005-10-12 2009-03-03 Lifenet Health Composition for repair of defects in osseous tissues
US7498040B2 (en) 2005-10-12 2009-03-03 Lifenet Health Compositions for repair of defects in osseous tissues, and methods of making the same
US8029575B2 (en) 2005-10-25 2011-10-04 Globus Medical, Inc. Porous and nonporous materials for tissue grafting and repair
WO2007056671A1 (en) 2005-11-02 2007-05-18 Osteotech, Inc. Hemostatic bone graft
JP5368102B2 (en) 2005-11-17 2013-12-18 バイオミメティック セラピューティクス, インコーポレイテッド Maxillofacial bone augmentation using rhPDGF-BB and a biocompatible matrix
EP1976460A4 (en) 2006-01-19 2012-06-20 Warsaw Orthopedic Inc Injectable and moldable bone substitute materials
WO2007084609A3 (en) 2006-01-19 2008-01-24 Osteotech Inc Porous osteoimplant
WO2007121345A3 (en) 2006-04-13 2008-06-26 Univ Case Western Reserve Biomaterial implants
US20070248575A1 (en) 2006-04-19 2007-10-25 Jerome Connor Bone graft composition
US8506983B2 (en) 2006-05-01 2013-08-13 Warsaw Orthopedic, Inc. Bone filler material
US20100209470A1 (en) 2006-05-01 2010-08-19 Warsaw Orthopedic, Inc. An Indiana Corporation Demineralized bone matrix devices
US7771741B2 (en) 2006-05-01 2010-08-10 Warsaw Orthopedic, Inc Demineralized bone matrix devices
US7951200B2 (en) 2006-07-12 2011-05-31 Warsaw Orthopedic, Inc. Vertebral implant including preformed osteoconductive insert and methods of forming
EP2049591A4 (en) 2006-08-02 2009-08-19 Polynovo Biomaterials Pty Ltd Biocompatible polymer compositions
US20080033572A1 (en) 2006-08-03 2008-02-07 Ebi L.P. Bone graft composites and methods of treating bone defects
US8449622B2 (en) 2006-09-11 2013-05-28 Warsaw Orthopedic, Inc. Multi-phase osteochondral implantable device
EP2073788A2 (en) 2006-09-28 2009-07-01 The Children's Medical Center Corporation Methods and collagen products for tissue repair
DE102006047248B4 (en) 2006-10-06 2012-05-31 Celgen Ag Three-dimensional artificial callus
US20080147197A1 (en) 2006-12-14 2008-06-19 Mckay William F Biodegradable osteogenic porous biomedical implant with impermeable membrane
US8048857B2 (en) 2006-12-19 2011-11-01 Warsaw Orthopedic, Inc. Flowable carrier compositions and methods of use
US8431148B2 (en) 2007-03-08 2013-04-30 Warsaw Orthopedic, Inc. Bone void filler
US20080233203A1 (en) 2007-03-21 2008-09-25 Jennifer Woodell-May Porous orthapedic materials coated with demineralized bone matrix
EP2139500A4 (en) 2007-03-27 2012-06-20 Univ Southern California Device which enhances the biological activity of locally applied growth factors with particular emphasis on those used for bone repair
WO2008122594A3 (en) 2007-04-05 2009-07-30 Soheil Asgari Partially biodegradable therapeutic implant for bone and cartilage repair
WO2008143867A1 (en) 2007-05-15 2008-11-27 Stryker Corporation Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
KR101010284B1 (en) 2007-07-04 2011-01-24 재단법인서울대학교산학협력재단 Composition of bone formation with PHSRN-RGD containing oligopeptide
DE102007049931A1 (en) 2007-10-18 2009-04-23 Pharmatech Gmbh Device and method for the continuous production of spherical powder agglomerates
US9056150B2 (en) 2007-12-04 2015-06-16 Warsaw Orthopedic, Inc. Compositions for treating bone defects
US20090148495A1 (en) 2007-12-11 2009-06-11 Hammer Joseph J Optimum Density Fibrous Matrix
US8840913B2 (en) 2008-03-27 2014-09-23 Warsaw Orthopedic, Inc. Malleable multi-component implants and materials therefor
US20100082072A1 (en) 2008-03-28 2010-04-01 Sybert Daryl R Bone anchors for orthopedic applications
US20100004733A1 (en) 2008-07-02 2010-01-07 Boston Scientific Scimed, Inc. Implants Including Fractal Structures
US9132208B2 (en) 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
US20100049322A1 (en) 2008-08-19 2010-02-25 Warsaw Orthopedic, Inc. Osteochondral repair implants and methods
US20100168869A1 (en) 2008-12-31 2010-07-01 Howmedica Osteonics Corp. Tissue integration implant
WO2010117766A1 (en) 2009-03-30 2010-10-14 Osseous Technologies Of America Collagen biomaterial wedge
US20100268227A1 (en) 2009-04-15 2010-10-21 Depuy Products, Inc. Methods and Devices for Bone Attachment
US8397769B2 (en) 2009-04-17 2013-03-19 Abc Pharmatech S.R.L. Apparatus for transferring incoherent or liquid material
WO2010134102A1 (en) 2009-05-19 2010-11-25 Abc Pharmatech S.R.L. Apparatus and method for transferring powdered products
CN102097420B (en) 2009-12-10 2014-08-20 鸿富锦精密工业(深圳)有限公司 Light-emitting diode (LED) and manufacturing method thereof
WO2012068135A1 (en) 2010-11-15 2012-05-24 Zimmer Orthobiologics, Inc. Bone void fillers

Patent Citations (235)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180605B2 (en)
US6180606B2 (en)
US3949073A (en) 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4131597A (en) 1975-01-17 1978-12-26 Ernst Leitz Gmbh Bioactive composite material process of producing and method of using same
US3968567A (en) 1975-04-21 1976-07-13 Nevins Alan J Endodontic composition and method
US4233360A (en) 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4202055A (en) 1976-05-12 1980-05-13 Battelle-Institut E.V. Anchorage for highly stressed endoprostheses
US4192021A (en) 1976-05-12 1980-03-11 Batelle-Institut e.V. Bone replacement or prosthesis anchoring material
US4191747A (en) 1976-12-17 1980-03-04 Hans Scheicher Corrective agent for the covering and/or filling of bone defects, method for the preparation of same and method of using the same
US4237559A (en) 1979-05-11 1980-12-09 General Electric Company Bone implant embodying a composite high and low density fired ceramic construction
US4356572A (en) 1979-07-12 1982-11-02 Etablissement Public Dit: Agence Nationale De Valorisation De La Recherche (Anvar) Biodegradable implant useable as a bone prosthesis
US4412947A (en) 1979-09-12 1983-11-01 Seton Company Collagen sponge
US4429691A (en) 1979-10-08 1984-02-07 Mitsubishi Mining And Cement Company, Ltd. Method for filling in defects or hollow portions of bones
US4497075A (en) 1979-10-08 1985-02-05 Mitsubishi Mining & Cement Co., Ltd. Filler for filling in defects or hollow portions of bones
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4642120A (en) 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones
US4846838A (en) 1983-07-15 1989-07-11 Tdk Corporation Prosthetic body for bone substitute and a method for the preparation thereof
US4619655A (en) 1984-01-26 1986-10-28 University Of North Carolina Plaster of Paris as a bioresorbable scaffold in implants for bone repair
US4970298A (en) 1984-03-27 1990-11-13 University Of Medicine And Dentistry Of New Jersey Biodegradable matrix and methods for producing same
US4596574A (en) 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
EP0164483A1 (en) 1984-06-12 1985-12-18 Oscobal Ag Method of producing a bone replacement material
US4623553A (en) 1984-06-12 1986-11-18 Oscobal Ag Method of producing a bone substitute material
US4606910A (en) 1984-06-28 1986-08-19 Interface Biomedical Laboratories Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same
US4620327A (en) 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction
US4789663A (en) 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
EP0429438B1 (en) 1984-07-06 1996-08-28 Collagen Corporation Bone repair using collagen
US4629464A (en) 1984-09-25 1986-12-16 Tdk Corporation Porous hydroxyapatite material for artificial bone substitute
US4563350A (en) 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US5001169A (en) 1984-10-24 1991-03-19 Collagen Corporation Inductive collagen-based bone repair preparations
US4888366A (en) 1984-10-24 1989-12-19 Collagen Corporation Inductive collagen-based bone repair preparations
US5522894A (en) 1984-12-14 1996-06-04 Draenert; Klaus Bone replacement material made of absorbable beads
US5425770A (en) 1985-03-28 1995-06-20 Collagen Corporation Calcium phosphate/atelopeptide collagen compositions for bone repair
US4992226A (en) 1985-03-28 1991-02-12 Collagen Corporation Method of making molds with xenogeneic collagen/mineral preparations for bone repair
EP0197693A2 (en) 1985-03-28 1986-10-15 COLLAGEN CORPORATION (a Delaware corporation) Xenogeneic collagen/mineral preparations in bone repair
US4795467A (en) 1985-03-28 1989-01-03 Collagen Corporation Xenogeneic collagen/mineral preparations in bone repair
US5246457A (en) 1985-03-28 1993-09-21 Collagen Corporation Xenogeneic collagen/mineral preparations in bone repair
US4863856A (en) 1985-04-04 1989-09-05 Verax Corporation Weighted collagen microsponge for immobilizing bioactive materials
US4668295A (en) 1985-04-25 1987-05-26 University Of Dayton Surgical cements
US4693986A (en) 1985-06-25 1987-09-15 Orthomatrix, Inc. Ceramic process and products
US4776890A (en) 1985-12-18 1988-10-11 Collagen Corporation Preparation of collagen hydroxyapatite matrix for bone repair
US4698326A (en) 1985-12-20 1987-10-06 Regents Of The University Of Minnesota Composition and method for osseous repair
US4780450A (en) 1985-12-20 1988-10-25 The University Of Maryland At Baltimore Physically stable composition and method of use thereof for osseous repair
US5366508A (en) 1986-01-28 1994-11-22 Thm Biomedical, Inc Apparatus for biodegradable, osteogenic, bone graft substitute device
US5755792A (en) 1986-01-28 1998-05-26 Thm Biomedical, Inc. Method and apparatus for biodegradable, osteogenic, bone graft substitute device
US4774227A (en) 1986-02-14 1988-09-27 Collagen Corporation Collagen compositions for bone repair containing autogeneic marrow
US6311690B1 (en) 1986-03-27 2001-11-06 Gensci Orthobiologics, Inc. Bone repair material and delayed drug delivery system
US5904718A (en) 1986-03-27 1999-05-18 Biocoll Laboratories, Inc. Delayed drug delivery system
EP0243178A2 (en) 1986-04-22 1987-10-28 Collagen Corporation A marrow/collagen/mineral matrix for bone defect repair
EP0271668B1 (en) 1986-10-22 1991-12-18 Gesellschaft für Biotechnologische Forschung mbH (GBF) Growth stimulating material, process for its production, and therapeutic composition
US5154931A (en) 1986-10-22 1992-10-13 Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) Growth-stimulating material derived from porcine bone therefor and a manufacturing process
US5035715A (en) 1986-11-06 1991-07-30 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US5123925A (en) 1986-11-06 1992-06-23 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US5085861A (en) 1987-03-12 1992-02-04 The Beth Israel Hospital Association Bioerodable implant composition comprising crosslinked biodegradable polyesters
US4843112A (en) 1987-03-12 1989-06-27 The Beth Israel Hospital Association Bioerodable implant composition
US20020128722A1 (en) 1987-07-30 2002-09-12 Steven R. Jefferies Bone repair material and delayed drug delivery system
US4863732A (en) 1987-12-16 1989-09-05 Collagen Corporation Injectable composition for inductive bone repair
US5137534A (en) 1988-01-11 1992-08-11 Asahi Kogaku Kogyo K.K. Method for producing dental and medical bone prosthesis and bone prosthesis produced thereby
US5236704A (en) 1988-01-28 1993-08-17 Sumitomo Pharmaceuticals Co., Ltd. Controlled release formulation
US5053212A (en) 1988-04-20 1991-10-01 Norian Corporation Intimate mixture of calcium and phosphate sources as precursor to hydroxyapatite
US5952010A (en) 1988-04-20 1999-09-14 Norian Corporation Paste compositions capable of setting into carbonated apatite
US5024841A (en) 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US4950483A (en) 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
WO1990000892A1 (en) 1988-07-23 1990-02-08 Nitta Gelatin Inc. Hardening material for medical and dental use
US5552454A (en) 1988-08-09 1996-09-03 Henkel Kommanditgesellschaft Auf Aktien New materials for bone replacement and for joining bones or prostheses
US5573771A (en) 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
US5207710A (en) 1988-09-29 1993-05-04 Collagen Corporation Method for improving implant fixation
US5258029A (en) 1988-09-29 1993-11-02 Collagen Corporation Method for improving implant fixation
US4891359A (en) 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US5162114A (en) 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5171574A (en) 1989-02-23 1992-12-15 Stryker Corporation Bone collagen matrix for implants
US5422340A (en) 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
US5073373A (en) 1989-09-21 1991-12-17 Osteotech, Inc. Flowable demineralized bone powder composition and its use in bone repair
US5932207A (en) 1989-11-03 1999-08-03 Schmidt; Karlheinz Complex active ingredient for the production of biological parts, especially organs for living organisms: method for the production of the same and its use
US6468308B1 (en) 1990-05-29 2002-10-22 Stryker Corporation Synthetic bone matrix
US6077988A (en) 1990-05-29 2000-06-20 Stryker Biotech Corporation Synthetic bone matrix
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
US5152836A (en) 1990-09-27 1992-10-06 Mitsubishi Materials Corporation Hydraulic calcium phosphate cement composition and cement composition containing hardening liquid
US5231169A (en) 1990-10-17 1993-07-27 Norian Corporation Mineralized collagen
US5455231A (en) 1990-10-17 1995-10-03 Norian Corporation Mineralized collagen
US5262166A (en) 1991-04-17 1993-11-16 Lty Medical Inc Resorbable bioactive phosphate containing cements
US5443531A (en) 1991-04-29 1995-08-22 South African Medical Research Council Delivery system for biologically active growth or morphogenetic factors and to a method for preparing such a delivery system
US5769895A (en) 1991-04-29 1998-06-23 South African Medical Research Council Delivery system for biologically active growth or morphogenetic factors and a method for preparing such a delivery system
US5304577A (en) 1991-05-01 1994-04-19 Onoda Cement Co., Ltd. Medical or dental hardening compositions
US5338772A (en) 1991-06-20 1994-08-16 Merck Patent Gesellschaft Mit Beschrankter Haftung Implant material
US6118043A (en) 1991-06-26 2000-09-12 Merck Patent Gesellschaft Mit Beschrankter Haftung Bone replacement material with FGF
US5356629A (en) 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair
EP0522569A1 (en) 1991-07-12 1993-01-13 United States Surgical Corporation Composition for effecting bone repair
US5508267A (en) 1991-10-22 1996-04-16 Isis Innovation Limited Bioactive material
US5306303A (en) 1991-11-19 1994-04-26 The Medical College Of Wisconsin, Inc. Bone induction method
US5769897A (en) 1991-12-13 1998-06-23 Haerle; Anton Synthetic bone
WO1993012736A1 (en) 1991-12-30 1993-07-08 Norian Corporation Mineralized collagen
US6013853A (en) 1992-02-14 2000-01-11 The University Of Texas System Continuous release polymeric implant carrier
US5204382A (en) 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US5352715A (en) 1992-02-28 1994-10-04 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US5320844A (en) 1992-03-12 1994-06-14 Liu Sung Tsuen Composite materials for hard tissue replacement
US5433751A (en) 1992-04-03 1995-07-18 Inoteb Bone prosthesis material containing calcium carbonate particles dispersed in a bioresorbable polymer matrix
US5532217A (en) 1992-04-24 1996-07-02 Silver; Frederick H. Process for the mineralization of collagen fibers, product produced thereby and use thereof to repair bone
US5739286A (en) 1992-04-24 1998-04-14 Silver; Frederick H. Bone augmentation material
US5399361A (en) 1992-05-01 1995-03-21 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
US5522893A (en) 1993-03-12 1996-06-04 American Dental Association Health Foundation Calcium phosphate hydroxyapatite precursor and methods for making and using the same
US5711957A (en) 1993-05-13 1998-01-27 Inoteb Use of a porous calcium carbonate based material as support of a growth factor in the preparation of a bioabsorbable implant
US5531791A (en) 1993-07-23 1996-07-02 Bioscience Consultants Composition for repair of defects in osseous tissues, method of making, and prosthesis
US5681873A (en) 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5824087A (en) 1994-04-11 1998-10-20 Aberdeen University And Plasma Biotal Limited Bone regeneration
US5955438A (en) 1994-07-19 1999-09-21 Colbar R & D Ltd. Collagen-based matrix
US6540784B2 (en) 1994-08-08 2003-04-01 Board Of Regents, The University Of Texas System Artificial bone implants
US20010005797A1 (en) 1994-08-08 2001-06-28 Barlow Joel W Artificial bone implants
US6183515B1 (en) 1994-08-08 2001-02-06 Board Of Regents, The University Of Texas System Artificial bone implants
US5846312A (en) 1994-08-23 1998-12-08 Norian Corporation Storage stable calcium phosphate cements
US6180606B1 (en) 1994-09-28 2001-01-30 Gensci Orthobiologics, Inc. Compositions with enhanced osteogenic potential, methods for making the same and uses thereof
US6180605B1 (en) 1994-09-28 2001-01-30 Gensci Orthobiologics, Inc. Composition with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
US5707962A (en) 1994-09-28 1998-01-13 Gensci Regeneration Sciences Inc. Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof
US5830493A (en) 1994-09-30 1998-11-03 Yamanouchi Pharmaceutical Co., Ltd. Bone-forming graft
US5709934A (en) 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US5741329A (en) 1994-12-21 1998-04-21 Board Of Regents, The University Of Texas System Method of controlling the pH in the vicinity of biodegradable implants
US5549671A (en) * 1994-12-28 1996-08-27 Mcghan Medical Corporation Adjunctive filler material for fluid-filled prosthesis
US6277151B1 (en) 1995-05-19 2001-08-21 Etex Corporation Cartilage growth from cell seeded ceramic compositions
US6214368B1 (en) 1995-05-19 2001-04-10 Etex Corporation Bone substitution material and a method of its manufacture
US6331312B1 (en) 1995-05-19 2001-12-18 Etex Corporation Bioresorbable ceramic composites
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US5650176A (en) 1995-05-19 1997-07-22 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US6139578A (en) 1995-05-19 2000-10-31 Etex Corporation Preparation of cell seeded ceramic compositions
US6027742A (en) 1995-05-19 2000-02-22 Etex Corporation Bioresorbable ceramic composites
US5683461A (en) 1995-05-19 1997-11-04 Etex Corporation Synthesis of reactive amorphous calcium phosphates
US6287341B1 (en) 1995-05-19 2001-09-11 Etex Corporation Orthopedic and dental ceramic implants
US5677284A (en) 1995-06-06 1997-10-14 Regen Biologics, Inc. Charged collagen particle-based delivery matrix
WO1996039203A1 (en) 1995-06-06 1996-12-12 Gensci Regeneration Laboratories, Inc. Modified osteogenic materials
US6028242A (en) 1995-06-07 2000-02-22 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
US6013856A (en) 1995-06-07 2000-01-11 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
EP0747067A2 (en) 1995-06-07 1996-12-11 Collagen Corporation Moldable collagen compositions for hard tissue repair and augmentation
US20020106394A1 (en) 1995-06-07 2002-08-08 Tucker Marjorie M. Terminally sterilized osteogenic devices and preparation thereof
US5618339A (en) 1995-07-20 1997-04-08 Matsumoto Dental College Osteoinduction substance, method of manufacturing the same, and bone filling material including the same
US20020042657A1 (en) 1995-09-01 2002-04-11 Millenium Biologix, Inc. Synthetic biomaterial compound of calcium phosphate phases particularly adapted for supporting bone cell activity
US6203573B1 (en) 1995-10-11 2001-03-20 Osteobiologics, Inc. Method of making biodegradable implant material and products made therefrom
US6764517B2 (en) 1995-10-16 2004-07-20 Depuy Acromed, Inc. Tissue repair matrix
US20040220680A1 (en) 1995-10-16 2004-11-04 Depuy Acromed, Inc. Tissue repair matrix
US5776193A (en) 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
WO2003071991A1 (en) 1995-10-16 2003-09-04 Depuy Acromed, Inc. Tissue repair matrix
US6187047B1 (en) 1995-10-16 2001-02-13 Orquest, Inc. Bone grafting matrix
US6902584B2 (en) 1995-10-16 2005-06-07 Depuy Spine, Inc. Bone grafting matrix
US20010014830A1 (en) 1995-10-16 2001-08-16 Orquest, California Corporation Bone grafting matrix
US6165487A (en) 1996-09-30 2000-12-26 Children's Medical Center Corporation Methods and compositions for programming an organic matrix for remodeling into a target tissue
US6346123B1 (en) 1996-10-24 2002-02-12 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
US6524345B1 (en) 1996-10-25 2003-02-25 Bionx Implants Oy Surgical implant
US5990381A (en) 1996-11-13 1999-11-23 Ise International, Co., Ltd. Biomedical materials
US20020034532A1 (en) 1996-12-20 2002-03-21 Brodbeck Kevin J. Injectable depot gel composition and method of preparing the composition
US6281195B1 (en) 1997-02-07 2001-08-28 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
US5964805A (en) 1997-02-12 1999-10-12 Stone; Kevin R. Method and paste for articular cartilage transplantation
US20010016772A1 (en) 1997-03-07 2001-08-23 Lee David A. Tissue implant
US6306169B1 (en) 1997-03-07 2001-10-23 Abonetics Ltd. Tissue implant
US20020098222A1 (en) 1997-03-13 2002-07-25 John F. Wironen Bone paste
WO1998040113A1 (en) 1997-03-13 1998-09-17 University Of Florida Tissue Bank, Inc. Bone paste
US6187046B1 (en) 1997-03-14 2001-02-13 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone material and process for the production of the same
US20010014662A1 (en) 1997-03-20 2001-08-16 David C Rueger Improved osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US5948426A (en) 1997-05-03 1999-09-07 Jefferies; Steven R. Method and article to induce hematopoietic expansion
US6309422B1 (en) 1997-06-20 2001-10-30 Alfred Farrington Bone grafting material
US5837752A (en) 1997-07-17 1998-11-17 Massachusetts Institute Of Technology Semi-interpenetrating polymer networks
US5910315A (en) 1997-07-18 1999-06-08 Stevenson; Sharon Allograft tissue material for filling spinal fusion cages or related surgical spaces
EP0901795A3 (en) 1997-09-11 2000-11-29 JOHNSON &amp; JOHNSON MEDICAL, INC. Buffered wound dressing materials
US5997895A (en) 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6136029A (en) 1997-10-01 2000-10-24 Phillips-Origen Ceramic Technology, Llc Bone substitute materials
US20010053937A1 (en) 1997-10-01 2001-12-20 Johnson James R. Bone substitutes
US6425949B1 (en) 1997-10-07 2002-07-30 Dr. H. C. Robert Mathys Stiftung Hydraulic surgical cement
US6037519A (en) 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
US6187329B1 (en) 1997-12-23 2001-02-13 Board Of Regents Of The University Of Texas System Variable permeability bone implants, methods for their preparation and use
US20010014667A1 (en) 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20020018796A1 (en) 1998-01-28 2002-02-14 John F. Wironen Thermally sterilized bone paste
US6123731A (en) 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US5958430A (en) 1998-02-20 1999-09-28 Battelle Memorial Institute Thin film composition with biological substance and method of making
EP1127581B1 (en) 1998-02-27 2005-06-15 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
US6326018B1 (en) 1998-02-27 2001-12-04 Musculoskeletal Transplant Foundation Flexible sheet of demineralized bone
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US6384197B1 (en) 1998-03-24 2002-05-07 Merck Patent Gesellschaft Process for the preparation of mineralized collagen fibrils and their use as bone substitute material
US6384196B1 (en) 1998-03-24 2002-05-07 Merck Patent Gesellschaft Process for the preparation of mineralized collagen fibrils and their uses as bone substitute material
US6395036B1 (en) 1998-04-06 2002-05-28 Isis Innovation Limited Composite material and methods of making the same
US6203574B1 (en) 1998-04-14 2001-03-20 Asahi Kogaku Kogyo Kabushiki Kaisha Prosthetic bone filler and process for the production of the same
US20020055143A1 (en) 1998-08-07 2002-05-09 Tissue Engineering, Inc. Bone precursor compositions
US6511510B1 (en) 1998-09-15 2003-01-28 Isotis N.V. Osteoinductive ceramic materials
US20010014831A1 (en) 1998-12-14 2001-08-16 Scarborough Nelson L. Bone graft, method of making bone graft and guided bone regeneration method
US6136030A (en) 1999-01-12 2000-10-24 Purzer Pharmaceutical Co., Ltd. Process for preparing porous bioceramic materials
US20020082694A1 (en) 1999-02-04 2002-06-27 Mckay William F. Highly-mineralized osteogenic sponge compositions, and uses thereof
US7172629B2 (en) 1999-02-04 2007-02-06 Sdgi Holdings, Inc. Osteogenic paste compositions and uses thereof
US20020054901A1 (en) 1999-03-02 2002-05-09 Gainey Glenn Morris Methods and compositions for bone graft implants
US20010018614A1 (en) 1999-03-16 2001-08-30 Bianchi John R. Implants for orthopedic applications
US20010051834A1 (en) 1999-03-24 2001-12-13 Chondros, Inc. Method for composite cell-based implants
US6340648B1 (en) 1999-04-13 2002-01-22 Toshiba Ceramics Co., Ltd. Calcium phosphate porous sintered body and production thereof
EP1053739A1 (en) 1999-05-18 2000-11-22 Matsumoto Dental University Method of manufacturing an osteoconductive substance
US6479565B1 (en) 1999-08-16 2002-11-12 Harold R. Stanley Bioactive ceramic cement
US6300315B1 (en) 1999-08-28 2001-10-09 Ceramedical, Inc. Mineralized collagen membrane and method of making same
US6417166B2 (en) 1999-08-28 2002-07-09 Ceramedical, Inc. Thin mineralized collagen membrane and method of making same
US20010037014A1 (en) 1999-08-28 2001-11-01 Sung-Tsuen Liu Thin mineralized collagen membrane and method of making same
US20020082594A1 (en) 1999-10-02 2002-06-27 Cary Hata Injectable biomaterial and methods for use thereof
US7189392B1 (en) 1999-10-15 2007-03-13 Genetics Institute, Llc Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins
US20010031799A1 (en) 1999-12-28 2001-10-18 Shimp Lawrence A. Calcium phosphate bone graft material, process for making same and osteoimplant fabricated from same
US20030152606A1 (en) 2000-01-28 2003-08-14 Thomas Gerber Inorganic resorbable bone substitute material and production method
US20010041792A1 (en) 2000-02-03 2001-11-15 Donda Russell S. Extraction of growth factors from tissue
US20020018797A1 (en) 2000-05-19 2002-02-14 Fuzhai Cui Nano-calcium phosphates/collagen based bone substitute materials
US20020022885A1 (en) 2000-05-19 2002-02-21 Takahiro Ochi Biomaterial
US20020022883A1 (en) 2000-06-13 2002-02-21 Burg Karen J.L. Tissue engineering composite
US7229545B2 (en) 2000-06-21 2007-06-12 Biomet Deutschland Gmbh Process for the coating for metallic implant materials
US20020018798A1 (en) 2000-06-21 2002-02-14 Merck Patent Gesellschaft Mit Beschrankter Haftung Coating for metallic implant materials
US20020013626A1 (en) 2000-07-19 2002-01-31 Peter Geistlich Bone material and collagen combination for repair of injured joints
US6576015B2 (en) 2000-07-19 2003-06-10 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Bone material and collagen combination for repair of injured joints
US20060246150A1 (en) 2000-12-22 2006-11-02 Thorne Kevin J Composition and Process for Bone Growth and Repair
US20020082697A1 (en) 2000-12-22 2002-06-27 Damien Christopher J. Implantable osteogenic material
US6846327B2 (en) * 2001-05-01 2005-01-25 Amedica Corporation Radiolucent bone graft
US6903146B2 (en) 2001-05-02 2005-06-07 Pentax Corporation Prosthetic filler for a living body and method of manufacturing the prosthetic filler
US7105182B2 (en) 2001-07-25 2006-09-12 Szymaitis Dennis W Periodontal regeneration composition and method of using same
US20050053638A1 (en) 2001-10-19 2005-03-10 Junzo Tanaka Organic/inorganic composite biomaterials and process for producing the same
EP1437148A1 (en) 2001-10-19 2004-07-14 Japan Science and Technology Agency Organic/inorganic composite biomaterials and processes for producing the same
US20030232071A1 (en) 2002-04-18 2003-12-18 Gower Laurie B. Biomimetic organic/inorganic composites, processes for their production, and methods of use
US20060204580A1 (en) 2002-04-18 2006-09-14 Gower Laurie B Biomimetic organic/inorganic composites, processes for their production, and methods of use
US20040131562A1 (en) 2002-04-18 2004-07-08 Gower Laurie B. Biomimetic organic/inorganic composites, processes for their production, and methods of use
US20060204581A1 (en) 2002-04-18 2006-09-14 Gower Laurie B Biomimetic organic/inorganic composites, processes for their production, and methods of use
US7163965B2 (en) 2002-05-01 2007-01-16 Japan Science And Technology Agency Process for producing porous composite materials
WO2003092759A1 (en) 2002-05-01 2003-11-13 Japan Science And Technology Agency Method for preparing porous composite material
EP1500405A1 (en) 2002-05-01 2005-01-26 Japan Science and Technology Agency Method for preparing porous composite material
US20060093670A1 (en) 2002-06-20 2006-05-04 Yutaka Mizushima Sustained-release composition process for producing the same and preparation thereof
US7153938B2 (en) 2002-11-06 2006-12-26 National Institute For Materials Science Cross-linked apatite/collagen porous body containing self-organized apatite/collagen composite and its production method
WO2004078120A2 (en) 2003-02-28 2004-09-16 Fibrogen, Inc. Collagen compositions and biomaterials
WO2005081699A2 (en) 2003-04-18 2005-09-09 University Of Florida Biomimetic organic/inorganic composites, processes for their production, and methods of use
EP1642599A1 (en) 2003-05-26 2006-04-05 PENTAX Corporation Porous composite containing calcium phosphate and process for producing the same
WO2004103422A1 (en) 2003-05-26 2004-12-02 Pentax Corporation Porous composite containing calcium phosphate and process for producing the same
US20060292350A1 (en) 2003-05-26 2006-12-28 Katsumi Kawamura Porous composite containing calcium phosphate and process for producing the same
US20050089579A1 (en) 2003-09-12 2005-04-28 Rebecca Li Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
WO2005051447A1 (en) 2003-10-28 2005-06-09 Cambridge University Technical Services Limited Composite biomaterials comprising calcium phospate materials, collagen and glycosaminoglycans
US20050199156A1 (en) 2004-02-10 2005-09-15 Ibrahim Khairoun Macroporous, resorbable and injectible calcium phosphate-based cements (MCPC) for bone repair, augmentation, regeneration, and osteoporosis treatment
US20050217538A1 (en) 2004-03-31 2005-10-06 Technische Universitat Dresden Modified Calcium Phosphate Bone Cement
WO2005099785A1 (en) 2004-04-15 2005-10-27 Nexilis Ag Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix
WO2006031196A1 (en) 2004-09-14 2006-03-23 Agency For Science, Technology And Research Porous biomaterial-filler composite and a method for making the same
WO2006092718A2 (en) 2005-03-04 2006-09-08 Fin-Ceramica Faenza S.P.A. Cartilaginiform and osteochondral sustitute comprising a multilayer structure and use thereof
US20060270037A1 (en) 2005-05-25 2006-11-30 Pentax Corporation Collagen-coated carrier and method for manufacturing collagen-coated carrier
WO2007053850A2 (en) 2005-11-01 2007-05-10 Osteotech, Inc. Bone matrix compositions and methods
US20080152687A1 (en) * 2006-12-21 2008-06-26 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof

Non-Patent Citations (29)

* Cited by examiner, † Cited by third party
Title
Alpaslan, C. et al., Bone reaction to subperiosteally implanted hydroxyapatite/collagen/glycosaminoglycans and coral in the guinea pig, Oral Surg. Oral Med. Oral Path., vol. 77, No. 4 (1994), 335-340.
Asahina, I. Repair of Bone Defect in Primate Mandible using a Bone Morphogenetic Protein (BMP)-Hydroxyapatite-Collagen Composite, J. Med. Dent. Sci., vol. 44 (1997), 63-70.
Bar-Shavit, Z. et al., Glucocorticoids Modulate Macrophage Surface Oligosaccharides and Their Bone Binding Activity, J. Clin. Invest., vol. 73 (1984), 1277-1283.
Benque, E. et al., Tomodensitometric and Histologic Evaluation of the Combined Use of a Collagen Membrane and a Hydroxyapatite Spacer for Guided Bone Regeneration: A Clinical Report, Int. J. Oral Maxillofac. Implants, vol. 14 (1999), 258-264.
Borsato, K. et al., Measurement of Partition of Stress Between Mineral and Collagen Phases in Bone Using X-ray Diffraction Techniques, J. Biomechanics, vol. 30, No. 9 (1997), 955-957.
Cornell, C. et al., Multicenter Trial of Collagraft as Bone Graft Substitute, J. Orthop. Trauma, vol. 5, No. 1 (1991), 1-8.
Cornell, C., Initial clinical experience with use of Collagraft as a bone graft substitute, Techniques Orthop., vol. 7, No. 2 (1992), 55-63.
Galbavy, S. et al., Atelocollagen/Hydroxylapatite Composite Material as Bone Defects Fillers in the Experiment on Rats, Bratisl. Med. J., vol. 96 (1995), 368-370.
Grigoryan, A. et al., Time Course of Bone Defect Healing After Implantation in Them of Collagen-Hydroxyapatite Complexes: Experimental and Morphological Study, Stomatologia, vol. 75 (1996), 13-16.
Hamson, K. et al., Preliminary Experience with a Novel Model Assessing In Vivo Mechanical Strength of Bone Grafts and Substitute Materials, Calcif. Tissue Int., vol. 57 (1995), 64-68.
Hsu, F. et al., Microspheres of hydroxyapatite/reconstituted collagen as supports for osteoblast cell growth, Biomaterials, vol. 20 (1999), 1931-1936.
International Search Report, mailed Mar. 7, 2008.
Ito, M., In vitro properties of a chitosan-bonded hydroxyapatite bone-filling paste, Biomaterials, vol. 12 (1991), 41-45.
Katthagen, B. et al., Experimental Animal Investigation of Bone Regeneration with Collagen-Apatite, Arch. Orthop. Trauma Surg. vol. 103 (1984), 291-302.
Kocialkowski, A. et al., Clinical experience with a new artificial bone graft: preliminary results of a prospective study, injury, vol. 21 (1990), 142-144.
Kubler, N. et al., "Bone Morphogenetic Protein-Mediated interaction of Periosteum and Diaphysis: Citric Acid and Other Factors Influencing the Generation of Parosteal Bone", Clinical Orthopaedics and Related Research, No. 258, Sep. 1990, pp. 279-294.
Linder, L. et al., Electron Microscopic Analysis of the Bone-Titanium Interface, Acta Orthop. Scand., vol. 54 (1983), 45-52.
Linder, L. et al., Electron Microscopic Analysis of the Bone—Titanium Interface, Acta Orthop. Scand., vol. 54 (1983), 45-52.
Lindholm, T. et al., The role of autogeneic bone marrow in the repair of a skull trephine defect filled with hydroxyapatite granules in the rabbit, Int. J. Oral Maxillofac. Surg., vol. 23 (1004), 306-311.
Mehlisch, D. et al., Histologic evaluation of the bone/graft interface after mandibular augmentation with hydroxylapatite/purified fibrillar collagen composite implants, Oral Surg. Oral Med. Oral Pathol., vol. 70 (1990), 685-692.
Minabe, M. et al., Histological Study fo the Hydroxyapatite-Collagen Complex Implants in Periodontal Osseous Defects in Dogs, J. Periodontol., (Oct. 1988), 671-678.
Mittelmeier, H. et al., Clinical Experience in the Implantation of Collagen-Apatite for Local Bone Regeneration, Z. Orthop., vol. 121 (1983), 115-123.
Noah, E.M. et al., "Impact of Sterilization of the Porous Design and Cell Behavior in Collagen Sponges Prepared for Tissue Engineering", Biomaterials, vol. 23, 2002, pp. 2855-2861.
Pasquier, G. et al., Injectable percutaneous bone biomaterials: an experimental study in a rabbit model, J. Mat. Sci. Mat. Med., vol. 7, No. 11 (1996), 683-690.
Pohunkova, H. et al., Reactivity and the fate of some composite bioimplants based on collagen in connective tissue, Biomaterials, vol. 16 (1995), 67-71.
Rovira, A. et al., Colonization of a calcium phosphate/elastin-solubilized peptide-collagen composite material by human osteoblasts, Biomaterials, vol. 17 (1996), 1535-1540.
St. John, K. et al., Response of Canine Bone to a Synthetic Bone Graft Material, Clin. Mat., vol. 12 (1993), 49-55.
Suganuma, J. et al., In vivo Evaluation of Collagen-Coated Dacron Fiber in Bone, Clin. Mat., vol. 15 (1994), 43-50.
Zerwekh, J. et al., Fibrillar Collagen-Biphasic Calcium Phosphate Composite as a Bone Graft Substitute for Spinal Fusion, J. Orthop. Res., vol. 10 (1992), 562-572.

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8690874B2 (en) 2000-12-22 2014-04-08 Zimmer Orthobiologics, Inc. Composition and process for bone growth and repair
US7887598B2 (en) 2002-06-13 2011-02-15 Kensey Nash Bvf Technology, Llc Devices and methods for treating defects in the tissue of a living being
US20090110710A1 (en) * 2002-06-13 2009-04-30 Evans Douglas G Devices and methods for treating defects in the tissue of a living being
US8742072B2 (en) * 2006-12-21 2014-06-03 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
US8546456B2 (en) 2008-07-25 2013-10-01 Smith & Nephew, Inc. Fracture fixation systems
US9730740B2 (en) 2008-07-25 2017-08-15 Smith & Nephew, Inc. Fracture fixation systems
US20110157056A1 (en) * 2009-12-23 2011-06-30 Colin Karpfinger Tactile touch-sensing interface system
US8613938B2 (en) 2010-11-15 2013-12-24 Zimmer Orthobiologics, Inc. Bone void fillers
US9220596B2 (en) 2010-12-23 2015-12-29 Biostructures, Llc Bone graft materials and methods
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
WO2013106318A1 (en) 2012-01-09 2013-07-18 Zimmer, Inc. Composite device that combines porous metal and bone stimuli
US9566156B2 (en) 2012-01-09 2017-02-14 Zimmer, Inc. Composite device that combines porous metal and bone stimuli
US8790402B2 (en) 2012-01-09 2014-07-29 Zimmer, Inc. Composite device that combines porous metal and bone stimuli
WO2013169475A1 (en) 2012-05-08 2013-11-14 Neal David J Porous spacers, instruments, and methods for foot and ankle fusion
WO2013190534A2 (en) 2012-06-13 2013-12-27 Technische Universität Dresden Homogenized compact composite, method for producing same, and composite powder and use thereof
DE102012209909A1 (en) * 2012-06-13 2013-12-19 Technische Universität Dresden Homogenized Kompaktkomposit, process for its preparation and composite powder and its use
DE102012209909B4 (en) * 2012-06-13 2014-10-30 Technische Universität Dresden Homogenized Kompaktkomposit, process for its preparation and composite powder and its use
WO2015147795A1 (en) * 2014-03-24 2015-10-01 Cormatrix Cardiovascular, Inc Sternal closure apparatus, system and method
WO2015147794A1 (en) * 2014-03-24 2015-10-01 Cormatrix Cardiovascular, Inc. Artificial skeletal material and constructs formed therefrom
US9381218B2 (en) 2014-03-24 2016-07-05 Cermatrix Cardiovascular, Inc. Artificial skeletal material and constructs formed therefrom

Also Published As

Publication number Publication date Type
US20080152687A1 (en) 2008-06-26 application
EP2109444B1 (en) 2016-07-13 grant
CA2673337C (en) 2014-09-16 grant
JP2010512967A (en) 2010-04-30 application
US20100196489A1 (en) 2010-08-05 application
CA2673337A1 (en) 2008-06-26 application
EP2109444A1 (en) 2009-10-21 application
WO2008076604A1 (en) 2008-06-26 application
US8742072B2 (en) 2014-06-03 grant
JP5399264B2 (en) 2014-01-29 grant

Similar Documents

Publication Publication Date Title
Hing et al. Comparative performance of three ceramic bone graft substitutes
US7214765B2 (en) High density fibrous polymers suitable for implant
US7045141B2 (en) Allograft bone composition having a gelatin binder
US6331312B1 (en) Bioresorbable ceramic composites
Nandi et al. Orthopaedic applications of bone graft & graft substitutes: a review.
US5246457A (en) Xenogeneic collagen/mineral preparations in bone repair
Takahashi et al. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate
US6953594B2 (en) Method of preparing a poorly crystalline calcium phosphate and methods of its use
US6949251B2 (en) Porous β-tricalcium phosphate granules for regeneration of bone tissue
US6703038B1 (en) Injectable bone substitute material containing non-ceramic hydroxyapatite cement
US20020076429A1 (en) Bone paste subjected to irradiative and thermal treatment
Damien et al. Bone graft and bone graft substitutes: a review of current technology and applications
US7517539B1 (en) Method of preparing a poorly crystalline calcium phosphate and methods of its use
Parikh Bone graft substitutes: past, present, future.
US6118043A (en) Bone replacement material with FGF
US20020082694A1 (en) Highly-mineralized osteogenic sponge compositions, and uses thereof
US20020018796A1 (en) Thermally sterilized bone paste
US6911212B2 (en) Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
Fleming et al. Bone cells and matrices in orthopedic tissue engineering
US20030049328A1 (en) Porous beta-tricalcium phosphate granules and methods for producing same
US6139578A (en) Preparation of cell seeded ceramic compositions
US20030158302A1 (en) Mineral-polymer hybrid composition
US6117456A (en) Methods and products related to the physical conversion of reactive amorphous calcium phosphate
Kuemmerle et al. Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty–an experimental study in sheep
Oryan et al. Bone regenerative medicine: classic options, novel strategies, and future directions

Legal Events

Date Code Title Description
AS Assignment

Owner name: ZIMMER ORTHOBIOLOGICS, INC., TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THORNE, KEVIN J.;REEL/FRAME:019057/0135

Effective date: 20070102

Owner name: ZIMMER ORTHOBIOLOGICS, INC.,TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THORNE, KEVIN J.;REEL/FRAME:019057/0135

Effective date: 20070102

FPAY Fee payment

Year of fee payment: 4

MAFP

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552)

Year of fee payment: 8